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Toxicology

The Role of Silicates in Interstitial Lung Disease
Chairperson or Co-Chairperson: Mark A. Pershouse
Interstitial Lung disease (ILD), produces disruption of alveolar walls with loss of
functionality and accumulation of scar tissue. Asbestosis and silicosis are the ILD
produced by the inhalation of asbestos fibers or silica particles respectively. An increase
in prostacyclin release after exposing endothelial cells to asbestos has been reported. This
study attempts to elucidate the role of lung epithelial cells in the generation of asbestos
induced ILD. A cell model to study crocidolite-induced toxicity was developed using
LA-4 cells, previously characterized as alveolar type II cells. LA-4 cells when exposed to
crocidolite had a decrease in viability and an increase in the release of LDH and 6-keto
PGF1α, a prostacyclin metabolite. Prostacyclin release was Cox 2 and vitronectin receptor
(VNR) mediated. Coating crocidolite asbestos with vitronectin enhances its
internalization via VNR, which also recognize the Arg-Gly-Asp (RGD) motif present in a
variety of ligands (e.g., vitronectin, fibronectin). These findings propose that crocidolite
is coated by an RGD protein and binds VNR inducing Cox 2 expression promoting
prostacyclin release. Cytotoxicity did not follow the same model. In silica studies, it has
been previously reported that Scavenger receptor A I/II (SR-A I/II) plays a role in silicainduced apoptosis. The cytoplasmic domain of the SR-AI/II has four aminoacids: Ser25,
Ser32, Ser53, Thr34 that can be phosphorylated, and the extracellular region contains a
lysine-rich cluster that is required for Acetylated Low density lipoprotein (AcLDL)
binding. SR-AI contains a cysteine-rich domain, which is absent in SR-AII. This study
evaluated the role of the four aminoacids that could be phosphorylated, and differences
between SR-AI and SR-AII in silica binding. Constructs expressing SR-AII, and mutated
SR-AIIs containing deletions to Ser25, Ser32, Ser53, Thr34 and KE (lysine cluster) were
generated and CHO cells were transfected. Receptor functionality was verified by
AcLDL uptake. Silica binding or silica-induced apoptosis was not statistically significant
different from transfected controls. In addition, no statistically significant difference was
found between SR-AI and SR-AII in AcLDL uptake, silica binding, and silica-induced
apoptosis. This study shows that asbestos or silica alone cannot induce its effect, and
asbestos required to be coated by RGD proteins.
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Chapter 1
Interstitial Lung Disease

Interstitial lung diseases (ILD) are a large and heterogeneous group of lower
respiratory tract disorders that share certain pathogenic mechanisms and histopathologic
features. ILD is also known as “Interstitial pulmonary fibrosis” or “Diffuse parenchymal
lung disease.” The prevalence of ILD in the general population is estimated to be 20 to 40
per 100,000 and accounts for 100,000 hospital admissions each year (Toews, 2000).
Several factors such as an increase in the use of pneumotoxic drugs prescribed to treat
malignancies, cardiovascular diseases, or organ transplantation, and the increase in the
identification of occupationally-induced ILD have contributed to an increase in its
incidence.
The human respiratory system includes the following regions: the nasal cavity,
pharynx, larynx, trachea, bronchi and their smaller branches, and the lungs. (Figure 1.1).
The histology of the respiratory system is complex in the proximal regions and simple in
the distal regions as shown in Figure 1.2 (Marieb & Hoehn, 2007; Powel, 1998). The
human respiratory tract contains over 40 different cell types, such as epithelial cells lining
in the airways, alveoli and blood vessels as well as connective tissue cells. The affected
structure in ILD is the alveolar interstitium, which involves the space between the
alveolar epithelium and the capillary endothelium including the connective tissues
surrounding blood vessels, lymphatic vessels, and airways. Despite the presence of some
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pathologic differences, the common denominator among ILDs is the widespread
disruption of alveolar walls with loss of functional alveolar capillary units and
accumulation of collagenous scar tissue also described as fibrosis.
The clinical presentation of ILD includes the triad: progressive dyspnea or
shortness of breath, evident radiographic interstitial infiltrates, and pulmonary function
tests showing a decrease in volume and gas diffusion. The clinical classification of ILD is
described in Table 1.1. It shows that ILDs could be divided into five groups. This study
focuses in the Environment/Occupation–associated ILD. Occupational diseases affecting
the pulmonary interstitium and producing ILD include primarily the pneumoconiosis or
dust diseases of the lung, and hypersensitivity pneumonitis. The principal
pneumoconioses are shown in Table 1.2. The term pneumoconiosis can be defined as
“the accumulation of dust in the lungs and the tissue reactions to its presence” (R. S.
Fraser et al., 2005). The most prevalent pneumoconioses are the ones caused by silicates
such as asbestos and silica. Pneumoconiosis as a consequence of silicate exposure
produced significant morbidity and mortality during the early part of the twentieth
century. Today silicate exposure in the workplace has been reduced through enforcement
of strict regulations in US, but due to the latency period between exposure and disease,
new cases of silicate pneumoconiosis are still detected in the general population (Kelley,
1998).
Silicate is chemically defined as a compound with one or more central silicon
atoms surrounded by electronegative ligands, most often oxygen atoms. Because the most
abundant elements in the continental crust are oxygen (45.2% weight) and silicon (27.2%
weight), high silicate abundance (30%) in the Earth’s crust is not surprising (Covey,
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2006; Whitehead, 2001). Structurally, silicates are classified into six subclasses:
Nesosilicates, Sorosilicates, Inosilicates, Cyclosilicates, Phyllosilicates, and
Tectosilicates (Table 1.3). Silica belongs to the tectosilicate and the asbestos amphibole
crocidolite to the inosilicate sub class (Figure 1.3).
Every day the respiratory system is exposed to large amounts of air through
respiration. The calculated amount of air mobilized by an adult is 15 to 20 m3 per day.
Due to this large amount of air volume, a considerable amount of inhaled particles could
accumulate in the lungs despite their low concentrations in the environment. The
principal mechanisms of inhaled particle deposition in the respiratory tract are impaction,
sedimentation, interception, and diffusion (Figure 1.4) (McClellan, 1999; Raabe, 1999).

A. Impaction is the dominant mechanism of deposition of particles larger than 3 µm in
aerodynamic diameter. It occurs when the particles follow their initial path because of
inertia rather than following changes in direction or speed of the airflow, resulting in
collision with the wall of the airway usually near a bifurcation.
B. Sedimentation of particles occurs when the airflow is slow and particle deposition is
influenced by gravity. As particles increase in aerodynamic diameter the
sedimentation increases.
C. Interception is a non-inertial incidental contact with the airway wall. It is more
important for fibers (e.g. asbestos) because their length (not their diameter) increases
the probability that the ends of the fiber will deposit by interception on the walls of
the airway.
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D. Diffusion is responsible for the deposition of particles smaller than 0.5 µm in
diameter. As particle size decreases, diffusion increases. Deposition by diffusion is
highest in the alveoli where the airflow is very slow

Particle deposition can occur in any portion of the respiratory system, but for the
development of pneumoconioses, the deposit has to occur in the distal regions, such as
the terminal bronchioles and alveoli. The great majority of particles that penetrate to the
alveoli are 1 µm or less in diameter. Larger particles are deposited on the upper
respiratory tract, trachea, and larger bronchi (Figure 1.5). Asbestos fibers are the
exception because they can penetrate the lung parenchyma despite their length of 30 µm
or more (R. S. Fraser, Colman et al., 2005). After the noxious agent (e.g. silica or
asbestos) reaches the lung, several factors in exposed individuals may play a role in their
susceptibility to develop ILD. Nemery et al., proposed four factors: First: differences in
delivery and/or persistence of the noxious agent could be related to innate anatomical or
physiological characteristics, and to acquired changes. Second: genetic or acquired
variations in enzymatic and non-enzymatic defense systems mainly related to protection
against oxidative stress. Third: the immunological sensitization that is dependent on
genetic and environmental factors. And fourth, the propensity to develop particular types
of reaction such as granulomas, and the ability to regulate and resolve inflammation and
fibrogenesis (Nemery et al., 2001).
The cause of most ILDs is unknown. Different agents such as bacteria, virus,
fungi, toxic agents, and environmental agents have been implicated. It has been proposed
that these agents can activate inflammatory or immune cells in the lung, or alternatively
4

these agents could produce direct injury to the resident pulmonary cells leading to an
inflammatory response initiated by the injured lung tissue. Because most of the time more
than one agent is present, it is possible to conclude that ILD is produced by a
combination of factors that induce direct and indirect inflammation, and affect the selflimited inflammatory response. In the past it was proposed that an insult initiated an
inflammatory response leading to a cycle of chronic inflammatory injury leading to
fibrosis. As a consequence, anti-inflammatory therapy was the primary therapy in the
hope that an interruption of the inflammatory cascade before irreversible tissue injury
occurred would benefit patients with ILD. However, in many cases, the use of antiinflammatory agents such as glucocorticoids and cytotoxics failed to improve the
outcome (Mason et al., 1999). Therefore, a new hypothesis has been proposed focusing
on the alveolar surface of the lung. It has been suggested that a stimulus (e.g. asbestos,
beryllium) produces repeated episodes of lung injury and the damaged alveolar
epithelium induces accumulation and activation of immuno-inflammatory cells, with
subsequent migration and proliferation of fibroblasts and extracellular matrix deposition
leading to the development of foci of fibroblasts/myofibroblasts in the alveolar
interstitium. This wound healing process leads to fibrosis and loss of lung function
(Clement et al., 2004; Gross & Hunninghake, 2001) (Figures 1.6 and 1.7).

The pathogenesis of ILD can be divided into three steps:
I. Epithelial damage: Epithelial cell injury is a hallmark of ILD. In situations of extensive
cell damage and/or inappropriate re-epithelialisation of the lung surface, the normal
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interaction between alveolar epithelial cells, inflammatory cells and interstitial
fibroblasts is altered resulting in an unbalanced production of inflammatory mediators.
II. Intra-alveolar inflammation: Inflammatory exudate accumulates and inflammatory cells
such as macrophages, neutrophils and lymphocytes increase in number in the alveolar
walls and in the alveolar air spaces. The inflammatory cell recruitment process, which
depends on production of cytokines and chemokines, includes the following four steps:
sequestration of inflammatory cells in pulmonary vessels, transmigration of the
vascular wall, migration through the extracellular matrix, and selective tissue retention.
III. Intra-alveolar fibrosis/alveolar collapse: The local population of fibroblasts and
myofibroblasts increases, leading to a progressive aberrant tissue remodeling process
with deposition of extracellular matrix components, including fibrillar collagen, elastic
fibers, fibronectin and proteoglycans. Under the influence of growth factors and
angiogenic molecules, epithelial cells proliferate and convert the fibrin-rich exudate in
fibrotic tissue producing scars and changes in the normal lung architecture.

In order to understand the mechanisms involved in the cellular activation during
the interaction between particle and cells from the lung, the agents chosen in this study
were crocidolite and silica. Crocidolite was chosen due to its high ability to induce
pulmonary fibrosis, and silica because is the most studied silicate in our laboratory.
Understanding this response will contribute the development of new strategies for clinical
intervention in silicate pneumoconiosis.
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Crocidolite Asbestos
Asbestos is a naturally occurring fibrous hydrated silicate mineral widely used in
the past for commercial applications. In the last century, more than 30 million tons of
asbestos have been mined, processed and applied in the United States (Mossman et al.,
1990; Mossman & Gee, 1989). Asbestos exposure can be classified into two groups:
occupational and non-occupational. Occupational exposure occurs during mining and
milling of the fibers, or during industrial application of asbestos in textiles, insulation,
shipbuilding, brake lining mechanics, etc. Non-occupational exposure is related to
fugitive asbestos fibers released into the environment and material inadvertently brought
home and released from contaminated clothing or other asbestos contaminated materials
(Kamp & Weitzman, 1997).
Despite the fact that most occupational asbestos exposure ceased in the late
1970’s due to governmental legislation, asbestos-related disease is still a public health
concern because: a) approximately 27 million workers in U.S. have been exposed, b) the
latency period involved between initial exposure and asbestos-related disease which is 20
years or longer, c) the continued presence of construction material containing great
amounts of asbestos, d) it is still used in over 3,000 products in US and e) the increase in
death rate due to asbestos-related disease (Kamp & Weitzman, 1997). Asbestos-related
diseases integrate several different kinds of diseases related to previous exposure to
asbestos fibers. The spectrum of thoracic diseases includes benign pleural effusion,
pleural plaques, diffuse pleural thickening, rounded atelectasis, asbestosis, mesothelioma,
and lung cancer. Asbestosis is the ILD produced by the inhalation of asbestos fibers.
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Asbestos forms fine, fibrous crystals and exhibits different properties such as high
tensile strength and durability, flexibility and malleability, thermal and chemical
resistance, and low electrical conductivity. Due to these properties, asbestos had been
used widely in many industrial and commercial applications. There are two primary
classes of asbestos: serpentine and amphibole (Figure 1.8). Serpentine fibers are curlystranded structures. Chrysotile (Mg6Si4O10(OH)8), a white or greenish colored asbestos
generally considered to be a less toxic fiber is the only commercial serpentine asbestos
and accounts more than 90% of asbestos used in the United States. Amphiboles fibers are
straight, rigid and needlelike. Three examples of amphiboles fibers are: crocidolite
(Na2Fe2+3Fe3+2Si8O22(OH)2) a blue sodium iron silicate fiber that may be woven or spun
into cloth or tape, tremolite a white to yellowish calcium magnesium silicate that has
been a major ingredient in industrial and commercial talc, and amosite (Fe7Si8O22(OH)2) a
brownish-yellow to white asbestos mineral used for heat insulation (Faust, 1995). Despite
their differences in physical properties, all types of asbestos fibers are fibrogenic, but
crocidolite is considered the most carcinogenic (Khan et al., 2004).
In the last 30 years numerous studies have been performed using different kinds
of asbestos and cell types. It has been established that alveolar macrophages (Bissonnette
et al., 1990; Tatrai et al., 2005), alveolar type II cells (Tatrai, Brozik et al., 2005),
mesothelial cells (Boylan et al., 1995; Wu et al., 2000), fibroblasts (MacCorkle et al.,
2006), and endothelial cells (Garcia et al., 1989; Garcia et al., 1988) can generate
different responses when exposed to asbestos fibers. These different responses include
DNA damage, gene transcription, and expression of proteins modulating cell
proliferation, cell death, and inflammation (Kamp et al., 1992; Mossman & Churg, 1998;
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Mossman, Kamp et al., 1996; Rom et al., 1991). In addition, several factors have been
found related to the pathogenesis of asbestos induced lung injury: a) chemical and
structural properties of the fiber, b) fiber burden in the lung, c) uptake by pulmonary
epithelial cells, d) iron catalysed free radicals, e) DNA damage, f) induction of cytokines
and growth factors, and g) cigarette smoke (Kamp & Weitzman, 1999). All these findings
give an idea about the complexity of the lung response after asbestos exposure (Figure
1.9). In a PubMed search performed on March 2007, the phrase “asbestos related disease”
was used. Approximately 15% of publications were about asbestosis, while most of the
published work were about mesothelioma a malignancy associated with asbestos
exposure.
In order for asbestos to initiate asbestosis or other asbestos related disease it needs
to come in contact with and be recognized by the target cell. In 1995 Boylan et al,
reported in rabbit mesothelial cells that coating crocidolite asbestos with vitronectin
enhanced its internalization via the alpha V integrin vitronectin receptor αvβ5 (Boylan,
Sanan et al., 1995). Integrins are a large family of cell surface receptors described as
heterodimeric, transmembrane glycoproteins composed of an α and a β subunit
noncovalently associated. Each αβ combination has its own binding specificity and
signaling. Most integrins can recognize more than one extracellular matrix (ECM) protein
and conversely, ECM proteins such as fibronectin, laminins, collagens, and vitronectin
can bind to more than one different integrin as well. Integrins can signal through the cell
membrane in either direction: inside-out signaling (induce changes in the environment)
and outside-in signaling (induce changes inside the cell); and transmit signals that
regulate the activities of cytoplasmic kinases, growth factor receptors, and ion channels
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and control the organization of actin cytoskeleton. Many integrin signals converge on cell
cycle regulation, directing cells to survive or die, proliferate, or exit the cell cycle and
differentiate (Giancotti, 2000; Giancotti & Ruoslahti, 1999; Kampman & McDonald,
1996). Vitronectin receptors (VNRs) comprise a group of integrins sharing a common αv
subunit. Based on their β subunit five different VNRs have been described: αvβ1, αvβ3,
αvβ5, αvβ6, and αvβ8. VNR and some integrins recognize the Arg-Gly-Asp (RGD)
motif present in a variety of ligands such as vitronectin, fibronectin, osteopontin, bone
sialoprotein, thrombospondin, fibrinogen, von Willebrand factor, tenascin, and agrin
(Converse, 2006; Roberts et al., 1991; Ruoslahti, 2003; Sheppard, 2005). Vitronectin is a
multifunctional protein present in blood serum and in the extracellular matrix.
Structurally, vitronectin contains an RGD motif that binds integrins, and other binding
domains for plasminogen activator inhibitor-1, urokinase receptor, thrombinantithrombin III complex, collagen, plasminogen, and heparin. It also contains proteolytic
cleavage and phosphorylation sites (McKusick, 1989; Schvartz et al., 1999). Vitronectin
promotes diverse biological functions such as cell adhesion, spreading and migration,
fibrinolysis, cell proliferation, etc (Figure 1.10). Its deposition has been detected in areas
of fibrosis and necrosis in different diseases (Seiffert, 1997). Following the observations
by Boylan et al. additional studies have reported the involvement of the VNR and RGD
motif in crocidolite internalization and toxicity (Boylan, Sanan et al., 1995; W. Liu et al.,
2000; Pande et al., 2006; Wu, Liu et al., 2000).
In studies performed in endothelial cells, an increase in the release of PGI2
(Prostacyclin) has been reported after asbestos exposure (Garcia, Dodson et al., 1989;
Garcia, Gray et al., 1988). Prostacyclin is a product of arachidonic acid metabolism
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(Figure 1.11) and is well established as a potent vasodilator and inhibitor of platelet
aggregation in contrast to the Thromboxane effect (Helliwell et al., 2004; McKusick,
2001). Due to this effect, it has been suggested that changes in the homeostasis between
prostacyclin and thromboxane could lead to endothelial damage, a component for the
development of ILD. Due to the lack of studies attempting to elucidate the role of lung
epithelial cells in the generation of asbestos induced ILD, we propose the following
general hypothesis: “Lung epithelial cells have the ability to respond when exposed to
asbestos.” The results of these studies examining the roles of VNR and prostacyclin in
epithelial response to crocidolite asbestos are detailed in Chapter 2.
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Silica
Silicosis and asbestosis, which share similar clinical findings, have been classified
as occupational diseases. Both are caused by the inhalation of silicates (silicon dioxide,
SiO2), which leads to a severe lung inflammation, accompanied by destruction of lung
tissue, development of ILD, and death. Silicosis is induced by the inhalation of free
crystalline silica (tectosilicate). The crystalline forms include cristobalite, tridymite and
quartz. All of them can produce ILD (Kelley, 1998). Silica exposure occurs more
frequently in granite quarrying and processing, crushed stone industries, foundries,
ceramics industry, and in construction and sandblasting operations (Table 1.4). Unlike
many other inhalation diseases, silicosis and asbestosis are diseases that progress even
after exposure has ceased (R. S. Fraser, Colman et al., 2005). In the U.S. between 1979
and 1992, 4882 death certificates listed silicosis as the cause of death. In European
countries the silicosis mortality ranged from 0.91 to 7.36 per 100,000 men (Wagner,
1997). This broad ranged was due to differences in degree of exposure, occupations, and
mortality reports among different countries. Silica particles, after reaching the alveoli, are
phagocytized by the resident alveolar macrophages (AM). Macrophages containing silica
undergo apoptosis releasing the particles that will be taken up by other AM. This
permanent cycle of phagocytosis-apoptosis contributes to the induction of ILD (Wang et
al., 2003; Wang et al., 2005).
Macrophage cell membrane receptors can recognize a broad range of endogenous
and exogenous ligands. The macrophage scavenger receptor A (SR-A) is a pattern
recognition receptor able to interact with polyanionic ligands with different levels of
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affinity (Gordon, 2002). SR-A was initially described as a binding site on macrophages
mediating the uptake and degradation of acetylated low density lipoprotein (AcLDL)
(Goldstein et al., 1979). It has been reported that SR-A has an important role in the
process of silica-induced apoptosis but the mechanism is still unknown (Chao et al.,
2001; R. F. Hamilton et al., 2000; R. F. Hamilton et al., 1996; Iyer et al., 1996). SR-A has
the ability to bind different kind of ligands such as modified LDL, silica, asbestos, LPS,
etc; and also has an important role in cell adhesion (I. Fraser et al., 1993; Peiser &
Gordon, 2001; Platt & Gordon, 2001) (Table 1.5). SR-AI, SR-AII, and SR-AIII are three
alternative splice variants of the scavenger receptor A gene. SR-AIII is not functional and
stays in the endoplasmic reticulum (Gough et al., 1998). Structurally SR-A is a trimeric
transmembrane protein with an N-terminus cytoplasmic region and a glycosylated fibrous
coiled extracellular region. SR-A contains five domains: 1) cytoplasmic, 2)
transmembrane, 3) spacer, 4) α-helical coiled-coiled, and 5) collagenous. SR-AI contains
an additional 6th domain called cysteine-rich (Kodama et al., 1990) (Figure 1.12). The
role of the cytoplasmic domain in receptor surface expression and modified LDL
internalization has been already described by Morimoto et al. and Kosswig et al.
(Kosswig et al., 2003; Morimoto et al., 1999). The cytoplasmic region in the human,
rabbit, bovine, dog and mouse contains between 50 to 55 amino acids, with a consensus
of more than 40% amino acids. The mouse sequence of SRA-II contains twelve amino
acids that could be phosphorylated (Ser and Thr). Four of these amino acids are common
in the SR-A sequence of five species (Figure 1.13). These amino acids correspond to
Ser25, Ser32, Ser53, and Thr34 in the SR-A mouse sequence. Based on this information,
it is possible that these four amino acids play an important role in the SR-A signaling.

13

Currently, it is unknown how SR-A initiates its intracellular signaling. In one
study heat shock proteins 90 (HSP90), HSP70 and GAPDH were found to interact with a
synthetic peptide containing the sequence of the cytoplasmic domain of SR-A (T.
Nakamura et al., 2002), but it was not possible to conclude that these proteins bind SR-A
after activation. In another study, where AcLDL was used to activate SR-A, it was found
that the cytoplasmic tyrosine kinase Lyn interacts with SR-A (Miki et al., 1996).
Unfortunately, it is not possible to conclude that SR-A responds to silica in the same way
as to AcLDL. Most of the research studies in SR-A and macrophages were done using
modified LDL and measuring binding and uptake of these lipoproteins, with no reported
studies on the cellular mechanism of silica-induced apoptosis in macrophages.
A highly conserved lysine cluster is found in the extracellular collagenous domain
of SR-A corresponding to human, murine, rabbit, bovine, and dog when they are aligned
(Figure 1.14). It has been proposed that this structure forms a positively charged groove
that interacts with negatively charged ligands such as modified LDL (Yamamoto et al.,
1997) and crocidolite asbestos (Resnick et al., 1993). Doi et al and Andersson et al
independently mutated these lysines in bovine SR-AI and rabbit SR-AII respectively
reporting a remarkable reduction in AcLDL binding and degradation (Andersson &
Freeman, 1998; Doi et al., 1993). An interesting finding reported in both papers was that
when binding experiments were performed at 4°C, the SR-A lacking the lysines was still
able to bind AcLDL.
Levels of expression of each SR-A splicing variant have been studied. Geng et al
reported similar levels of SR-AI and SR-AII mRNA in human circulating monocytes,
however when monocytes were differentiated into macrophages or macrophage-derived
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foam cells, a selective increase in SR-AI mRNA levels was found (Geng et al., 1994).
Dufva et al reported, using monocyte derived macrophages, greater down-regulation of
SR-AII mRNA after LPS exposure, and in the presence of cycloheximide, selective
degradation of SR-AI mRNA (Dufva et al., 1995). A third study performed by Kim et al
with peritoneal macrophages (PMs) found no SR-A protein in freshly isolated PMs and
minimal AcLDL uptake. However, when PMs were cultured in vitro for 3 days,
expression of SR-A protein and AcLDL uptake were considerably increased. Due to the
lack of differences in SR-A mRNA levels between the fresh and 3-days cultured PMs, it
was concluded that SR-A expression is post-transcriptionally regulated (Kim et al.,
1997).
As mentioned above, the key difference between SR-AI and SR-AII is that SR-AI
contains a cysteine rich domain also known as scavenger receptor cysteine rich domain
(SRCR). Because previous studies comparing SR-AI and SR-AII binding properties
including the mutated lysines were performed using modified LDL as ligands, the general
affirmation that SR-AI and SR-AII bind the same ligands is limited only to modified
LDL. Ashkenas et al in 1993 reported no difference in polyanion binding specificity
between SR-AI and SR-AII, but in an experiment using ReLPS as a competitive
inhibitor, SR-AII transfected cells showed almost a complete inhibition of AcLDL
degradation in comparison with SR-AI transfected cells (Ashkenas et al., 1993). In
addition, Resnick et al reported that bovine SR-AI binds crocidolite asbestos more
efficiently than bovine SR-AII (Resnick, Freedman et al., 1993). One explanation for
these two findings is that the SCRC domain of SR-AI is functional and able to interact
with ReLPS and Crocidolite asbestos. Moreover, another SR-A receptor called MARCO,
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also has a SRCR domain, which is functional and very important for its ligand-binding
function (Chen et al., 2006).
Since there are no studies evaluating the role of the SR-A cytoplasmic domain in
silica-induced apoptosis or comparing binding properties between SR-AI and SR-AII
using silica as particulate ligands, the following general hypothesis was generated: “Silica
binding to SR-A results in an induction of apoptosis mediated by a signal transduction
mechanism beginning at specific cytoplasmic domains, and the presence of the SCRC
domain in SR-AI increases the binding efficiency of silica.” This study is presented in
Chapter 3.
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Table 1.1
Clinical Classification of Interstitial Lung Disease (ILD)(Toews, 2000)
Primary Lung Diseases
Idiopatic pulmonary fibrosis
Sarcoidosis
Bronchiolitis obliterans with organizing pneumonia
Lymphocytic interstitial pneumonia
Histiocytosis X
Lymphangioleiomyomatosis
ILD Associated with Systemic Rheumatic Disorder
Rheumatoid arthritis
Systemic lupus erythematous
Polymyositis-dermatomyositis
Sjogren’s syndrome
Mixed connective tissue disease
Ankylosing spondylitis
ILD Associated with Drug or Treatments
Antibiotics
Anti-inflammatory agents
Cardiovascular drugs
Antineoplastic agents
Illicit drugs
Dietary supplements
Oxygen
Radiation
Paraquat
Environment/Occupation-Associated ILD
Organic dust/hypersensitivity pneumonitis (>40 known
agents)
Farmer’s lung
Air conditioner-humidifier lung
Bird breeder’s lung
Bagassosis
Inorganic dusts
Silicates
Silicosis
Asbestosis
Coal workers’ pneumoconiosis
Berylliosis
Gases/fumes/vapors
Oxides of nitrogen
Sulfur dioxide
Toluene diisocyanate
Oxides of metals
Hydrocarbons
Thermosetting resins
Alveolar Filling Disorders
Diffuse alveolar hemorrhage
Goodpasture’s syndrome
Idiopathic pulmonary hemosiderosis
Pulmonary alveolar proteinosis
Chronic eosinophilic pneumonia
ILD Associated with Pulmonary Vasculitis
Wegener’s granulomatosis
Churg-Strauss syndrome
Hypersensitivity vasculitis
Necrotizing sarcoid granulomatosis
Inherited Disorders
Familial idiopathic pulmonary fibrosis
Neurofibromatosis
Tuberous sclerosis
Gaucher’s disease
Niemann-Pick disease
Hermansky-Pudlak syndrome

17

Table 1.2
Principal Pneumoconioses Caused by Mineral Dust (Samet, 2000)

AGENT
Asbestos
Coal dust
Cobalt
Silica
Talc

DISEASE
Asbestosis
Coal workers’ pneumoconiosis
Hard metal disease
Silicosis
Talcosis
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Table 1.3
Silicate Subclasses (Covey, 2006; Whitehead, 2001)

Silicate subclass

Arrangement

Formula
4-

- Nesosilicates

Single tetrahedron

(SiO4)

- Sorosilicates

Double tetrahedral

(Si2O7)6-

Common Minerals
Olivine
Garnet
Kyanite
Sillimanite
Andalusite
Staurolite
Epidote

- Inosilicates
Single chain
Double chain

(SinO3n)2n(Si4nO11n)6n-

Pyroxene
Amphibole

- Cyclosilicates

Rings

(SinO3n)2n-

Tourmaline
Beryl

- Phyllosilicates

Sheets

(Si2nO5n)2n-

Illite
Chlorite
Serpentine
Kaolinite
Talc
Vermiculite

- Tectosilicates

3D frameworks

(AlxSiyO2(x+y))x- Quartz
Feldspars
Zeolites
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Table 1.4
Occupations and Industries Associated with Silicosis (Wagner, 1997)
Occupations
Mining-machine operators
Laborers
Managers and administrators
Supervisors, precision production occupations
Janitors and cleaners
Operators of molding and casting machines
Supervisors and proprietors, sales occupations
Operating engineers
Machinists
Hand-molding, casting, and forming occupations

Industries
Coal-mining
Construction
Metal-mining
Blast furnaces, steelworks, rolling and
finishing mills
Non-metallic mining and quarrying
Iron and steel foundries
Structural clay products
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Table 1.5
Macrophage Scavenger Receptor A Ligands (Peiser & Gordon, 2001; Platt &
Gordon, 2001)
Ligand
Oxidized low density lipoprotein
Acetylated low density lipoprotein
Oxidized high density lipoprotein
Maleylated bovine serum albumin
Malondialdehyde bovine serum albumin
Fucoidan
Dextran sulfate
Polyguanylic acid
Polyinosinic acid
Crocidolite asbestos
Silica
Lipopolysaccharide
Lipoteichoic acid
Gram negative bacteria
Gram positive bacteria
Apoptotic cells
AGE-modified proteins
β-amyloid

Non-ligand
Native low density lipoprotein
Native high density lipoprotein
Bovine serum albumin
Heparin
Chondroitin sulfate
Polycytidylic acid
Polyadenylic acid
Phosphatidylserine
Phosphatidylcholine

21

Figure 1.1
The Airway Tree (Weibel, 1963)
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Figure 1.2
Cellular Structure of Airways (Burri & Weibel, 1973)

EP, epithelium; BM, basement membrane; SM, smooth muscle; FC, fibrous coat and connective
tissue.
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Figure 1.3
A. Crocidolite asbestos fibers and B. Cristobalite silica (Mossman & Churg,
1998)

A

B
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Figure 1.4
Primary Mechanisms of Deposition of Inhaled Particles in the Respiratory
Tract (McClellan, 1999)
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Figure 1.5
Fractional Deposition of Inhaled Particles Related to Aerodynamic Particle
Diameter (McClellan & Miller, 1997)
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Figure 1.6
Original and New Hypothesis for the Pathogenesis of ILD (Gross &
Hunninghake, 2001)
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Figure 1.7
The Process Involved in the Development of ILD (Peterson & Schwartz, 1999)
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Figure 1.8
Schematic picture of the crystal structure of the asbestos class (A) serpentine,
and (B) Amphibole (Ottaviani et al., 2001)

A

B
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Figure 1.9
Mechanisms of Asbestos Induced Pulmonary Toxicity (Kamp & Weitzman,
1999)
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Figure 1.10
Major Biological Functions in which Vitronectin has been Implicated
(Schvartz, Seger et al., 1999)

GAG: glycosaminoglycan binding domain
UPAR: urokinase receptor
PAI-1: plasminogen activator inhibitor-1
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Figure 1.11
Prostacyclin Biosynthetic Pathway

Phospholipase A2

Arachidonic acid

Cyclooxygenase
PGH2

Prostacyclin
Synthase
Prostacyclin (PGI2)

6-keto-PGF1α
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Figure 1.12
Domains of Human Macrophage Scavenger Receptor A type I and II (Platt &
Gordon, 2001)
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Figure 1.13
Protein Alignment of the SRA Cytoplasmic Domain Among Different Species.
Rabbit
Dog
Human
Bovine
Mouse
consensus

-----MAQWDSFTDQQEDTDSCSESVKFDARSNTALLPPNPKNGPPLQEKLKSFKAA
-----MEPWDRFPDHQDDPDNYSESVKFDARSMTALLPLNPKNGPAVQEKLKSLKAA
-----MEQWDHFHNQQEDTDSCSESVKFDARSMTALLPPNPKNSPSLQEKLKSFKAA
-----MAQWDDFPDQQEDTDSCTESVKFDARSVTALLPPHPKNGPTLQERMKSYKTA
MTKEMTENQRLCPHEREDADCSSESVKFDARSMTASLPHSTKNGPSVQEKLKSFKAA
..... ......*.*...*********.**.**...**.*..**..**.*.*
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Figure 1.14
Protein Alignment of the SRA Lysine Cluster Among Different Species.
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Chapter 2
The Biological Response of Lung Epithelial Cells to Asbestos

Asbestosis is the ILD elicited by the inhalation of asbestos fibers. ILD are a large
and heterogeneous group of lower respiratory tract disorders. ILD is also known as
“Interstitial pulmonary fibrosis” or “Diffuse parenchymal lung disease. The cause of most
ILDs is unknown. It has been suggested that certain agents (e.g. asbestos, beryllium)
cause repeated episodes of lung injury. The damaged alveolar epithelium subsequently
induces accumulation and activation of inflammatory cells, which is coincident with the
migration and proliferation of fibroblasts and extracellular matrix deposition in the
alveolar interstitium leading to fibrosis and loss of lung function (Clement, HenrionCaude et al., 2004; Gross & Hunninghake, 2001).
A number of studies have shown that asbestos is cytotoxic for
epithelial/endothelial cells. Different mechanisms have been described to be involved in
the development of asbestos-induced pulmonary disease such as DNA damage, signaling
mechanisms, gene transcription and protein expression, mutagenicity, cell
death/apoptosis and inflammation (Kamp, Graceffa et al., 1992; Mossman, Bignon et al.,
1990; Mossman & Churg, 1998; Mossman, Kamp et al., 1996; Rom, Travis et al., 1991).
It has been postulated that asbestos-induced pathogenesis derives from an interplay
between persistent free radical production and expression of cytokines, growth factors,
and inflammatory cell products (Kamp & Weitzman, 1999). In addition, since the
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epithelial layer of the lung has a barrier function and serves as a likely sentinel following
asbestos inhalation, its chronic cell injury will compromise its protective function and
promote the development of ILD.
Coating crocidolite asbestos with vitronectin enhances its internalization via the
alpha V integrin VNR αvβ5 in mesothelial cells (Boylan, Sanan et al., 1995). VNRs, and
many other members of the integrin family such as α4β1, α5β1, α8β1, and αIIbvβ3
recognize the Arg-Gly-Asp (RGD) motif (Takagi, 2004) present in a variety of ligands
such as vitronectin, fibronectin, osteopontin, bone sialoprotein, thrombospondin,
fibrinogen, von Willebrand factor, tenascin, and agrin (Converse, 2006; Roberts,
Yokoyama et al., 1991; Ruoslahti, 2003; Sheppard, 2005). Additional studies have
reported the involvement of VNR and RGD motif in crocidolite internalization and
toxicity (W. Liu, Ernst et al., 2000; Pande, Mosleh et al., 2006; Wu, Liu et al., 2000).
Besides, in endothelial cells, an increase in the release of Prostacyclin has been reported
after asbestos exposure (Garcia, Dodson et al., 1989; Garcia, Gray et al., 1988). It has
been suggested that changes in the prostacyclin homeostasis could lead to endothelial
damage, a component for the development of ILD. Due to the lack of understanding of
the lung epithelial cell response to asbestos exposure and in the development of asbestos
induced ILD, and to determine VNR and/or prostacyclin involvement, this study was
performed in order to answer the following hypothesis.

37

Hypothesis
Lung epithelial cells interact with asbestos via vitronectin receptor resulting in
cellular toxicity and the initiation of an inflammatory response.

Aims
I.

Develop a cell model to study asbestos-induced lung toxicity.

II.

Evaluate the ability of asbestos to induce the inflammatory mediator PGI2
(Prostacyclin).

III.

Evaluate the role of Vitronectin receptor in asbestos-induced response.
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Aim I. Develop a cell model to study asbestos-induced lung
toxicity
This aim focused on the downstream consequences of lung epithelial cells
exposed to asbestos. Numerous studies have been performed evaluating different cells in
asbestos-induced response. Mesothelial cells are the most studied due to the relationship
between asbestos exposure and mesothelioma, a malignant pleural disease. Studies not
performed with mesothelial cells, had used primary (alveolar macrophages or
neutrophils) or immortalized cell lines (A549, WI-26, BEAS 2B, MET 5A, or HTE), both
obtained from different sources such as human, rat, and hamster (Kamp et al., 1994;
Kamp et al., 1998; Kinnula et al., 1995; Mossman, Surinrut et al., 1996; Tsuda et al.,
1999). In a PubMed search performed on April 2007, the terms “asbestos AND
epithelium AND murine” were used. Results showed 30 studies, most of them in-vivo
experiments or in mesothelial cells. It was not possible to find a study evaluating murine
lung epithelial cell line and asbestos exposure. In order to find an appropriate murine
epithelial cell line to perform crocidolite studies, this aim will compare immortalized
lung epithelial cells lines in order to determine which one is a better model for the study
of asbestos-induced responses. Initially two cell lines were selected due to laboratory
availability.

Methods
Cell Lines
Two epithelial cell lines were used:
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1) LA-4 cells: lung adenoma clone 4, derived from A/He mouse. Tumor was induced by
urethane exposure, and characterized as alveolar type II cell-like (Stoner et al., 1975).
Cell cultures were maintained in Ham's F12K medium (Mediatech, Inc., Herdon, VA)
supplemented with 2 mM L-glutamine adjusted to contain 100 units/ml of penicillin,
100 µg/ml streptomycin, 0.25 µg/ml amphotericin B (Mediatech, Inc.), and 15% fetal
bovine serum (Hyclone, Logan, UT).
2) CMT 64/67 cells: Spontaneous tumor in a C57BL/lcrf-at mouse, characterized as
papillary adenocarcinoma of the lung (Franks et al., 1976). Cells cultures were
maintained in RPMI 1640 medium (Mediatech, Inc.) adjusted to contain 1.0 mM
sodium pyruvate, 0.05 mM 2-mercaptoethanol, 100 units/ml of penicillin, 100 µg/ml
streptomycin, 0.25 µg/ml amphotericin B (Mediatech, Inc.), and 10% fetal bovine
serum (Hyclone).
Cell cultures were incubated at a temperature of 37ºC in an atmosphere of 95% air and
5% CO2 (ThermoForma, Mariette, OH).

Asbestos Exposure
All asbestos exposure experiments were performed using the amphibole
crocidolite, which was chosen due to its high toxicity in human studies (Enterline &
Henderson, 1973; Faust, 1995). Adherent LA-4 or CMT 64/67 cells were trypsinized
with 2-3 ml of Trypsin/EDTA (Mediatech Inc.), counted using a Z1 Coulter Particle
Counter (Beckman Coulter, Hialeah, FL), and plated 24 hours prior to exposure at 50,000
cells in a volume of 200 µl of media per well in a 96-well plate. Cell culture media was
changed at exposure time. Crocidolite stock suspension (10 mg/ml) was freshly made by
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mixing crocidolite obtained from Research Triangle Institute (Research Triangle Park,
NC) with sterile water. The suspension was sonicated using a Sonicator Ultrasonic
processor XL (Misonix, Franingdale, NY) for one minute, mixed with fresh cell culture
media and added to the 96-well plate. Cells were exposed to crocidolite for 24 hours
before performing any assessment unless indicated.

Cell Cytotoxicity Assays
Viability Assay: This colorimetric assay correlates with the number of viable cells in
proliferation. The conversion of MTS tetrazolium into aqueous soluble formazan is
accomplished by metabolically active cells. After exposure at doses described in results, a
volume of 100 µl of media was removed leaving 100 µl of media in each well. Twenty µl
of CellTiter96 AQueous One Solution Reagent from Promega (Madison, WI) was added
into each well and incubated for 1-4 hours at 37ºC in a humidified 5% CO2 atmosphere.
Optical density (OD) was measured using a microplate reader (Molecular Devices,
Sunnyvale, CA) at a wavelength of 490 and for reference at 650 nm. For normalizing,
each control group (non-exposed) was considered to have 100% viability.
Cytotoxicity Assay: LDH (lactate dehydrogenase) is an enzyme, which is abundant in the
cytosol. Its release correlates with loss of membrane integrity and cell death. LDH was
measured using the Cytotoxicity Detection Assay (LDH) (Roche Applied Science,
Indianapolis, IN), which contains a substrate that changes color in the presence of LDH.
Cells were plated 24 hours before exposure as previously described. At exposure time,
cell culture media was replaced with 1% FBS in order to decrease the LDH background
absorbance, as recommended by manufacturer. Triton X-100 (Sigma-Aldrich Inc., St
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Louis, MO) at 1% was used as a positive control. After exposure 100 µl of cell culture
media was transferred to a 96-well plate, mixed with 100 µl of reaction mixture, and
incubated for 30 minutes at room temperature and protected from light. OD was
measured at a wavelength of 492 and 650 nm. Cytotoxicity was calculated as a
percentage between minimum or 0% (non-exposed) and maximum or 100% (Triton X100) control values.

Statistical analysis
Experiments were repeated at least three times. Results were presented as the
mean and standard error of the mean (SEM) unless indicated. When required data was
normalized with its respective control in order to exclude differences in background
conditions such as presence of different culture media, chemical inhibitors, peptides,
bronchoalveolar lavaged fluid (BALF), and blocking antibodies. Data was analyzed using
student T test for independent variables, or nonparametric statistics methods as required
such as Mann-Whitney U test when comparing two groups, and Kruskal-Wallis test when
comparing three groups or more. Statistical analyses were performed using the software
GB-Stat version 6.5.6 (Dynamic Microsystems, Inc., Silver spring, MD). Alpha error was
set at p<0.05.

Results
In order to determine if crocidolite could induce toxicity in LA-4 and CMT 64/61
cells, a viability assay was performed using increasing doses of crocidolite. Three doses
of crocidolite were used: 5, 10, and 20 µg/cm2 and Triton X-100 (1%) for positive
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control. Only LA-4 cells showed a decrease in viability following a dose response mode
(Figure 2.1). In order to confirm these results, cytotoxicity assay was performed using the
crocidolite dose of 20 µg/cm2. The results showed an increase in LDH release in the
exposed group, confirming the results of the viability assay (Figure 2.2). On the other
hand CMT 64/61 cells were resistant to asbestos-induced toxicity at all doses used
(Figure 2.1). Only LA-4 cells were cytotoxic to crocidolite, consequently crocidolite
exposure experiments in Aims II and III were performed only on LA-4 cells.
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Aim II. Evaluate the ability of asbestos to induce the
inflammatory mediator PGI2 (Prostacyclin)
Asbestos is known to induce lung inflammation that progresses to fibrosis.
Prostacyclin release is an indicator of asbestos–induced cell activation and inflammation.
Prostacyclin has diverse effects in different cells. Previous studies in fibroblast showed
that exposure to prostacyclin analogues significantly inhibited contraction of extracellular
matrix (Kamio et al., 2007), in colonic epithelial cells exposed to butyrate, an apoptosis
inducer, prostacyclin confers an antiapoptotic effect (Cutler et al., 2003), and in
macrophages prostacyclin regulates phagocytosis, bacterial killing, and cytokine
generation (Aronoff et al., 2007). All these findings show the ability of prostacyclin to
interact with the different cells involved in the development of ILD. In murine lung
epithelial cells, the asbestos-induced prostacyclin induction has not been previously
described. Therefore, this aim will determine if prostacyclin release is induced in lung
epithelial cells after asbestos exposure.

Methods
6-keto Prostaglandin F1α Detection Assay
Prostacyclin is non-enzymatically hydrated to 6-keto PGF1α, which is a more
stable metabolite. In order to detect prostacyclin, experiments were directed to measure
6-keto PGF1α as an indicator of prostacyclin production. Cells were plated at 40,000 50,000 cells/well in a 96-well plate. After twenty-four hours crocidolite exposure at doses
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described in Results, 6-keto PGF1α was detected using an ACE™ (acetylcholinesterase)
competitive enzyme immunoassay (Cayman Chemical, Ann Arbor, MI) according to
manufacturer instructions. For each condition, 50 µl of cell culture media were
transferred to a pre-coated 96-well plate (mouse monoclonal anti rabbit IgG), mixed with
6-keto PGF1α tracer and antiserum (rabbit antiserum 6-keto PGF1α) and incubated for 18
hours at 4ºC. Plates were developed using Ellman’s Reagent for the detection of
acetylcholinesterase, and read at a wavelength of 405 nm.
Cyclooxygenase Inhibitors
The COX-1/COX-2 inhibitor Indomethacin, and the COX-2 inhibitor
Indomethacin Heptyl Ester were used at doses 10 and 100 times their respective IC50
(inhibitory concentration of 50% of the total activity) (Kalgutkar et al., 2000). Inhibitors
were added at the same time fresh cell culture media containing crocidolite was added to
the cells as previously described in Aim I.
Cox 2 real time polymerase chain reaction
Two to four hours after crocidolite exposure (10 µg/cm2), LA-4 cells were lysed
using Trizol reagent (Invitrogen, Carlsbad, CA) and total RNA was isolated following
manufacturer’s instructions. First strand reverse transcription was performed using
RETROscript™ (Ambion Inc., Austin, TX) with oligo dT primers, and amplification was
performed using the Platinum® Quantitative PCR SuperMix-UDG (Invitrogen)
following manufacturer’s recommendations. Real time probes and primers from murine
Cox 2 and GAPDH (endogenous control) were obtained from TaqMan® Gene
Expression Assays (Applied Biosystems, Foster City, CA). Amplification was run and
signals detected using an ABI Prism 7700 Sequence Detection System (Applied
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Biosystems). Ct values were recorded for each condition and Cox 2 data was analyzed
relative to GAPDH.

Results
As previously described, endothelial cells release prostacyclin when exposed to
asbestos. Since epithelial cells produce prostacyclin, it was important to determine if
crocidolite induced/augmented prostacyclin production in LA-4 cells. Prostacyclin
production through the detection of its metabolite 6-keto PGF1α was approached in LA-4
cells after crocidolite exposure at a final concentration of 10 µg/cm2 for 24 hours. A
statistically significant increase of prostacyclin metabolite was observed in the exposed
group (Figure 2.3). Prostacyclin production requires cyclooxygenase and the specific
isomerase prostacyclin synthase as previously described in Figure 1.9. There are two Cox
isoforms: Cox 1 (constitutively expressed) and Cox 2 (inducible). It has been shown that
prostacyclin biosynthesis is highly but not absolutely Cox 2 dependent (Belton et al.,
2000; Caughey et al., 2001). In order to determine which Cox isoform was involved in
prostacyclin increase, the Cox inhibitors Indomethacin (a Cox 1 and 2 inhibitor) and
Indomethacin heptyl ester (a specific Cox 2 inhibitor) were used. Reduction of
prostacyclin biosynthesis by the Cox 2 selective inhibitor Indomethacin heptyl ester (at a
dose of 10 times its respective IC50) suggested that asbestos exposure might induce higher
activity of Cox 2 (Figure 2.4).
Based of the previous findings using Cox inhibitors, it was necessary to determine
if asbestos was inducing the expression of Cox 2 mRNA in LA-4 cells. Cox 2 mRNA
was quantified using real time PCR. LA-4 cells were plated and exposed as previously
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described and lysed 2 and 4 hours after crocidolite exposure. LA-4 cell expression of Cox
2 mRNA increased more than 5 fold two hours after exposure to asbestos then returning
to its basal level 4 hours post exposure (Figure 2.5), suggesting a transitory increase.
Further studies to determine increases in protein expression of Cox 2 and prostacyclin
synthase by WB, and phospholipase A2 activity due to crocidolite exposure did not work
(data not shown), because the total amount of protein recovery in the cell lysate from the
crocidolite exposed groups were very low in comparison with the non-exposed groups
presumably due to the adsorption of proteins by crocidolite.
In order to determine if Cox 1/2 and prostacyclin contributed to asbestos-induced
cytotoxicity, cells were treated with Cox inhibitors at increasing doses before asbestos
exposure. Interestingly, after 24 hours of crocidolite exposure, Cox inhibitors did not
protect LA-4 cells from asbestos-induced cytotoxicity. All groups, either with or without
Cox inhibitors, showed a decrease in viability following a dose response mode with no
statistically significant difference when comparing exposed groups without Cox
inhibitors with exposed groups that received Cox inhibitors (Figures 2.6 and 2.7).
Apparently, indomethacin at a dose of 75 µM showed some cell protection from
crocidolite-induced cytotoxicity. But this effect was seen only in one of the three
experiments performed. Because Cox inhibitors prevented prostacyclin release and not
asbestos-induced cytotoxicity, it is possible to suggest that LA-4 cells have the ability to
respond in two different ways after crocidolite exposure: A cytotoxic response, which is
Cox independent, and a prostacyclin response, where the induction of Cox 2 appears to
be the primary event promoting prostacyclin biosynthesis. The next aim evaluated if
these different responses were receptor mediated.
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Aim III. Evaluate the role of Vitronectin receptor in asbestos
induced response
As previously described, asbestos after being coated with vitronectin, binds
mesothelial cells through vitronectin receptor (VNR) (Boylan, Sanan et al., 1995). This
aim will determine if asbestos induced-cytotoxicity and induction of Cox 2 and
prostacyclin biosynthesis is mediated through lung epithelial cell VNR.

Methods
Vitronectin Receptor Expression
Three hundred thousand LA-4 cells were labeled with fluorescent murine-specific
anti-αv antibody (anti-CD51, RMV-7, Armenian hamster IgG, phycoerythrin labeled)
purchased from BD PharMingen (San Jose, CA). After 20 minutes incubation at 4ºC,
fluorescence was detected on a FACSAria Flow cytometer using FACS Diva software
(Becton Dickson, Franklin Lakes, NJ). LA-4 cells with no fluorescent antibody were used
as control. In order to exclude dead cells from the analysis, Hoechst 33258 dye
(Invitrogen) was added to a final concentration of 1 µg/ml. Cells uptaking the dye were
considered dead cells.

Vitronectin Receptor Inhibition
RGDS peptide: The tetrapeptide Arg-Gly-Asp-Ser or RGDS (Sigma-Aldrich, St Louis,
MO) was used as a competitive inhibitor of VNR binding, and the Arg-Gly-Glu-Ser or
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RGES (Sigma-Aldrich) for non-specific binding control. Peptides were added at a final
concentration of 10 and 100 µg/ml simultaneously with crocidolite asbestos exposure as
previously described in Aim 1.
VNR blocking antibody (RMV-7): The blocking antibody RMV-7 was used to
specifically inhibit VNRs. RMV-7 antibody was added at a final concentration of 2 µg/ml
one hour before crocidolite exposure as previously described in Aim 1.

Bronchoalveolar lavaged fluid (BALF) isolation
BALB/c mice were obtained from our animal facility. Mice 6 to 8 weeks old were
used for BALF isolation. All animal procedures were approved by the University of
Montana Institutional Animal Care and Use Committee (IACUC). Five female mice were
euthanized by a lethal injection of Pentobarbital 0.1 ml of a 0.65% solution. Lungs were
surgically removed with the heart and lavaged one time only, in order to prevent dilution
of the BALF, with 0.9 ml of cold sterile phosphate buffered saline adjusted to contain
100 units/ml of penicillin, 100 µg/ml streptomycin, 0.25 µg/ml amphotericin B
(Mediatech, Inc.). All samples were mixed and centrifuged at 1,500 RPM for 10 minutes.
The BALF supernatant was separated and the cell pellet discarded.

Asbestos Exposure
LA-4 cells were trypsinized and plated as previously described in Aim I. At
exposure time media was changed to Opti-mem® I reduced serum medium (Mediatech,
Inc.), which contains minimal protein levels. Then BALF was added to a final
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concentration of 25% and also crocidolite to a final concentration of 10 and 15 µg/cm2.
Cells were incubated for 24 hours before performing any measurement.

Results
Flow cytometry was used to determine if LA-4 cells expressed a vitronectin
receptor. Antibodies recognizing the alpha v (αv) subunit revealed expression of this
chain on the surface of LA-4 cells. These findings verified that LA-4 cells express the
alpha v (αv) subunit, which is the common subunit in all VNR (Figures 2.8 and 2.9). In
order to determine if the prostacyclin production was VNR mediated, inhibitors of VNRs
such as RGDS peptides and blocking antibodies were used. In the groups exposed to
crocidolite (20 µg/cm2) and treated with either RGDS peptide or VNR blocking antibody
a statistically significant decrease in prostacyclin metabolite production was observed
confirming VNR involvement in the prostacyclin production (Figures 2.10 and 2.11).
In all previous experiments involving VNR it was assumed that the crocidolite
fibers were coated with the ECM proteins present in the fetal bovine serum of the cell
culture media. ECM proteins are present in many bodily fluids and since asbestos is
typically inhaled it was important to demonstrate similar effects at a physiologically
relevant concentration of ECM proteins in the airway/alveolar spaces. The simple way to
determine this was by harvesting BALF. LA-4 cells were exposed to crocidolite in the
presence of reduced serum media and BALF. LA-4 cells when present in reduced serum
media did not produce prostacyclin when exposed to crocidolite (Figure 2.12), however
when BALF was added to the reduced serum media, LA-4 cells released prostacyclin
when exposed to crocidolite (Figure 2.12). This finding suggests that proteins present in
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BALF (and also in fetal bovine serum) are required to induce the production of
prostacyclin. When viability was evaluated in the presence of reduced serum, LA-4 cells
were protected from crocidolite-induced toxicity, and the addition of BALF did not
increase the toxicity (Figure 2.13) suggesting that other factors (e,g, non-RGD ECM
proteins) present in the fetal bovine serum, but not in BALF, are required to induce
cytotoxicity of LA-4 cells when exposed to crocidolite.
As previously established, the cytotoxic response may be Cox independent. To
determine if a protein containing a RGD motif or if VNR were required for asbestosinduced cytotoxicity in LA-4 cells, cell toxicity assays as previously described in Aim I
were performed using RGDS peptide and VNR blocking antibody RMV-7. Neither
RGDS peptide nor RMV-7 prevented crocidolite-induced cytotoxicity (10 µg/cm2) of
LA-4 cells (Figure 2.14 and 2.15).

51

Aims III’. Characterize asbestos exposed floating cells
It has been previously reported that asbestos promotes cell detachment of alveolar
epithelial cells (Donaldson et al., 1993). In this study, it also was observed by light
microscopy that LA-4 cells exposed to asbestos detach forming floating clusters
composed of cells binding multiple asbestos fibers. This aim was an attempt to obtain
some preliminary data about floating cell viability and the VNR involvement in the
formation of these floating clusters.

Methods
Crocidolite Exposure
Cells were plated on a 25 cm2 flask 24 hours before crocidolite exposure. RMV-7
antibody was added 1 hour before exposure at a final concentration of 1.5 µg/ml.
Crocidolite final concentration used was 20 µg/cm2. Measurements were performed 24
hours after exposure.

Cell Count
Floating cells were collected from media, and counted by hemocytometer.

Cell Viability: Trypan Blue Exclusion
Collected floating cells were stained with Trypan Blue in a 1:1 dilution. Cells
excluding the dye were considered viable.
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Results
In order to verify if the increase in floating cells was real, culture media was
removed and cell counted. An increase in the number of floating cells was seen in the
crocidolite-exposed group (Figure 2.16). The viability of floating cells in the exposed
group was almost six times less than the unexposed one (Figure 2.17). In the presence of
VNR blocking antibody, RMV-7, a statistically significant decrease in the number of
floating cells was observed (Figures 2.18). When viability was evaluated after crocidolite
exposure, a statistically significant increase was observed in the group treated with RMV7 (Figures 2.19). Because asbestos exposure was affecting the total number of floating
cells, and viability was detected in percentage, Figure 2.20 was designed combining the
data from Figures 2.16, 2.17, 2.18, and 2.19 in order to visualize in absolute cell count
the effect of crocidolite exposure in viability with or without RMV-7, so no statistics
were performed. This figure shows that the groups exposed to crocidolite have higher
numbers of floating dead cells in comparison with the non-exposed groups, also that
RMV-7 by itself apparently did not increase the number of floating cells by blocking
VNR, and finally that RMV-7 decreased the number or floating dead cells in the
crocidolite-exposed group.
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Summary
LA-4 cells when exposed to crocidolite activate a pathway characterized by the
release of prostacyclin, which is Cox-2 and VNR mediated. Simultaneously a cytotoxic
pathway, which is Cox independent, is activated. Crocidolite induces cell detachment of
LA-4 cells, which seems to be VNR mediated. In addition, it seems that VNR plays a role
in the cytotoxic pathway of these floating cells.
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Discussion
Asbestos is known to induce lung inflammation that progresses to fibrosis. It has
been postulated that ILD develops in an inflammatory environment with altered repair
mechanisms. Crocidolite-induced direct damage to alveolar cells such as macrophages,
alveolar type I, or type II cells may generate the conditions required for ILD
development. Moreover, it is possible that alveolar type II cells independently could play
an important role, because they secrete pulmonary surfactant (in order to prevent alveolar
collapse) and replace the damaged type I cells by acting as a stem cell (Finkelstein &
Barrett, 2000). Direct damage to alveolar type II cells could create an inflammatory
environment and interference with the repair mechanisms related to type I cells
replacement, the conditions required for ILD development. This study compared two
immortalized murine lung epithelial cell lines in order to determine which one could be a
better model for the study of asbestos-induced responses. Results showed that crocidoliteinduced toxicity is cell type specific, because LA-4 cells were susceptible to crocidoliteinduced toxicity, while CMT 64/67 cells were resistant despite the high doses of
crocidolite used. So, it is possible that some receptors required for crocidolite interaction
be present in LA-4 cells and not in CMT 64/67 cells. LA-4 cells have been characterized
as alveolar type II cells (Stoner, Kikkawa et al., 1975), the same alveolar cell type that
plays an important role in ILD development. Consequently LA-4 cells were used in all
further crocidolite-exposure experiments in the present study
Prostacyclin release is an indicator of asbestos–induced cell activation and
inflammation (Garcia, Dodson et al., 1989; Garcia, Gray et al., 1988). Prostacyclin is a
product of arachidonic acid metabolism. Its production requires cyclooxygenase and the
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specific isomerase prostacyclin synthase as previously described in Figure 1.9. Due to its
instability, it is non-enzymatically hydrated to 6-keto PGF1α, a more stable metabolite. In
this study 6-keto PGF1α production was considered an indicator of prostacyclin synthesis.
Prostacyclin has diverse effects in different cells such as endothelial cells, epithelial cells,
macrophages, and fibroblasts as previously described. Curiously all these different cells
also could be playing a role in the development of ILD. This study has shown that murine
type II cells produce prostacyclin after asbestos exposure. This finding allows us to
propose that asbestos-induced prostacyclin release is a mechanism in which type II cells
could regulate the activity of different cell populations in the alveolar space and be
directly or indirectly involved in the development of ILD.
Prostacyclin synthesis requires Cyclooxygenase (Cox). There are two Cox
isoforms: Cox 1 (constitutively expressed) and Cox 2 (inducible). Several studies have
shown that prostacyclin biosynthesis is highly Cox 2 dependent, but this is not absolute
(Belton, Byrne et al., 2000; Caughey, Cleland et al., 2001). Lovgren et al. reported that
Cox 2 dependent prostacyclin production played an important role in the development of
lung fibrosis in the bleomycin-induced pulmonary fibrosis mouse model (Lovgren et al.,
2006). Murakami et al. reported that repeated administration of a long-acting prostacyclin
agonist attenuated the development of bleomycin-induced pulmonary fibrosis and also
improved survival in these mice (Murakami et al., 2006). The present study showed that
prostacyclin production, induced by crocidolite exposure, was prevented in the presence
of Cox 2 inhibitors, suggesting that prostacyclin production was Cox 2 dependent.
Moreover, a two-hour crocidolite exposure increased the expression of Cox 2 mRNA
five-fold in LA-4 cells. This increase was transitory, and probably adequate enough to
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maintain prostacyclin synthesis for a minimum of 24 hours. Based on the cited reports
and our findings it is possible to postulate that exposure of type II cells to crocidolite
induces Cox 2 and prostacyclin synthesis, which is Cox 2 dependent. This increase in
prostacyclin production could be a protective mechanism against the development of
crocidolite-induced pulmonary fibrosis. Unfortunately this effect is short-lived relative to
the direct toxicity of crocidolite on LA-4 cells. In this study, Cox inhibitors did not
protect LA-4 cells from asbestos-induced cytotoxicity. Since the use of the same Cox
inhibitors prevented prostacyclin release and did not protect the cells from asbestosinduced cytotoxicity, I propose that LA-4 cells respond in two different ways after
crocidolite exposure: A prostacyclin response, where the induction of Cox 2 appears to be
the primary event promoting prostacyclin biosynthesis, and cytotoxic response, which is
Cox independent.
As previously described, coating crocidolite asbestos with vitronectin enhances its
internalization via the alpha V integrin vitronectin receptor αvβ5 in mesothelial cells
(Boylan, Sanan et al., 1995). Vitronectin receptor (VNR) is a group of integrins sharing a
common αv subunit. Murphy et al. reported that engagement of the VNR αvβ3 induces
Cox 1 and Cox 2 expression in endothelial cells (J. F. Murphy et al., 2003). The present
study showed that LA-4 cells expressed the αv subunit, present in all vitronectin
receptors.
VNR and some other integrins recognize the Arg-Gly-Asp (RGD) motif present
in a variety of ligands such as vitronectin. RGD peptides have been previously used as
competitive inhibitors for receptors that recognized RGD domain (Roberts, Yokoyama et
al., 1991; Ruoslahti, 2003). Because VNR recognizes the RGD domain, this study used
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RGD peptides for the inhibition of VNR ligand binding. The use of RGD peptides
decreased prostacyclin production, after crocidolite exposure, more than 20%. Although
the decrease is statistically significant, it also suggests that other mechanisms, which do
not depend on the RGD domain recognition, are responsible for prostacyclin production
after crocidolite exposure.
The important role of TGFβ in healing and fibrosis and ILD has been well
established (Gross & Hunninghake, 2001; Pittet et al., 2001; Toews, 2000; Wang,
Scabilloni et al., 2005). As previously described, there are five different types of VNRs
(based on their β subunit): αvβ1, αvβ3, αvβ5, αvβ6, and αvβ8. It has been described
that VNRs αvβ6 and αvβ8 bind the TGFβ latency-associated peptide (LAP) inducing
activation of TGFβ in lung and skin, and that the β6 null mice are protected from
bleomycin-induced pulmonary fibrosis (Munger et al., 1999; Pittet, Griffiths et al., 2001).
In addition, VNRs αvβ1 and αvβ5 also bind directly to LAP, but without TGFβ
activation (Sheppard, 2005). So it is possible that VNRs involvement in asbestos-induced
ILD be through TGFβ activation. It was previously described that VNR αvβ5 enhances
internalization of vitronectin coated crocidolite fibers by mesothelial cells (Boylan, Sanan
et al., 1995; Pande, Mosleh et al., 2006). Because VNR αvβ5 also binds LAP, it is
possible to postulate that vitronectin-coated crocidolite fibers compete with LAP for
VNR αvβ5 binding. This competition might affect the amount of free LAP that
potentially could be activated to TGβ by other VNRs such as αvβ6 or αvβ8.
In this study, when VNRs were specifically blocked with an antibody, the
prostacyclin production after crocidolite exposure decreased more than 20%. Curiously,
this finding, which is consistent with the decrease found when RGD peptides were used,
58

favors the idea of VNR involvement in prostacyclin production after crocidolite
exposure. VNR inhibitors (RGD peptides and blocking antibody) induced only a 20%
decrease in the crocidolite-induced prostacyclin release. Because the 6-keto PGF1α assay
is an estimate of the total prostacyclin released in the last 24 hours after crocidolite
exposure, it would have been interesting to determine the effect of VNR inhibitors in the
trend of prostacyclin release over crocidolite exposure time in order to detect a further
decrease in crocidolite-induced prostacyclin release.
Vitronectin is a multifunctional protein with an RGD motif that is recognized by
different members of the integrin family including VNR (McKusick, 1989; Schvartz,
Seger et al., 1999; Takagi, 2004). Vitronectin coats asbestos fibers enhancing cell
internalization. It is a multifunctional adhesive protein present in large concentrations in
blood serum (Schvartz, Seger et al., 1999). It diffuses into the extravascular tissue where
it could bind some other proteins (Hayman et al., 1983). It has been found in
bronchoalveolar lavaged fluid (BALF) and pleural liquid, and in higher concentrations
during inflammatory states (Boylan, Sanan et al., 1995). In all previous asbestos exposure
experiments, it was assumed that the crocidolite fibers were coated with the ECM
proteins present in the fetal bovine serum of the cell culture media. Because most of the
asbestos exposure is typically by inhalation, it was important to demonstrate similar
effects at a physiologically relevant concentration of ECM proteins in the BALF. In this
study, when LA-4 cells were exposed to crocidolite in the presence of reduced serum
culture media, prostacyclin production was prevented; and when BALF was added,
prostacyclin production was rescued. These findings suggest that one or more factors
present in BALF (and in fetal bovine serum) are necessary to induce prostacyclin release
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in LA-4 cells exposed to crocidolite. Although this study did not look for the presence of
vitronectin in the BALF or fetal bovine serum our findings suggest some factor or factors
coats crocidolite fibers, favoring cell interaction and prostacyclin release. Surprisingly,
crocidolite cytotoxicity was prevented in the presence of reduced serum culture media,
and the addition of BALF did not rescue the cytotoxicity. This finding favors the
rationale that a factor or factors present in fetal bovine serum (e.g. ECM proteins) and not
in BALF is required to induce cytotoxicity. It is also possible that the same factor is
present in very low amounts in BALF, but during lung injury and inflammatory states,
the factor levels increase allowing crocidolite-induced cytotoxicity. Unexpectedly, when
RGD peptides or VNR blocking antibody were used in the presence of fetal bovine serum
in order to prevent crocidolite-induced cytotoxicity, LA-4 cells were not protected from
cytotoxicity. Since RGD peptides are expected to compete with any ECM protein
containing a RGD domain, it is possible to postulate that the RGD domain is not the only
one recognized by integrin (e.g. CS-1 domain), or that the RGD domain of some ECM
involved in cytotoxicity have higher affinity for the receptor than the RGD peptides,
reducing their competition ability.
The findings that VNR inhibitors did not prevent crocidolite-induced cytotoxicity,
strengthen the idea that LA-4 cells respond in two different pathways after crocidolite
exposure: A prostacyclin response, which is Cox 2 and VNR dependent, and cytotoxic
response, which is Cox and VNR independent. Both pathways could be associated with
the development of lung fibrosis, because they could be affecting the balance of bound
and free LAP. The prostacyclin pathway, which is VNR dependent, could promote LAP
release by competition as previously described, and the cytotoxic pathway decreases the
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number of cells binding LAP. In either pathway, free LAP is able to bind others VNRs
(such as αvβ6 or αvβ8) expressed in type II cells or other alveolar cells, inducing TGFβ
activation and promoting healing and/or fibrosis.
The findings with floating LA-4 cells raised additional issues: Do LA-4 cells bind
and grow on crocidolite fibers, detach from the bottom, and once floating they die; or do
the cells die first, detach, and form clumps with floating crocidolite fibers? The decrease
in floating cell number when crocidolite with VNR inhibitor was used favors the idea that
VNR interaction with asbestos is an early event before cell detachment, and allows to
postulate that LA-4 cells first bind crocidolite fibers through the VNR before detaching.
This statistically significant 20% decrease in floating cells number is consistent with
other experiments using VNR inhibitors. However a decrease of only 20% also suggest
that VNR is not the only receptor involved. Unexpectedly, cell viability increased more
than 50% in floating cells when VNR inhibitor was used. This finding apparently
contradicts the idea that cytotoxicity is VNR independent, but favors the idea that LA-4
cells initially bind crocidolite fibers through VNR (and/or by gravity as observed by light
microscopy that fibers do not float), then grow on the fibers, and finally detach. Once
cells start floating, gravity no longer plays a role keeping the fibers in contact with the
cells, but VNR role might be more important keeping crocidolite fibers in close contact
with the cell membrane and this way indirectly inducing cytotoxicity.
Figure 2.21 shows a proposed model for the alveolar type II cell response after
crocidolite exposure. First, an RGD protein present in fetal bovine serum and BALF
coats crocidolite. This RGD protein is a ligand for VNR. This interaction will induce Cox
2 expression and activity promoting prostacyclin release. Second, crocidolite also induces
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cytotoxicity independently from RGD protein, VNR, Cox 1 or Cox 2. And third, cells
bind RGD coated crocidolite fibers through VNR and detach from the bottom of the flask
forming floating clusters of cells attached to crocidolite fibers. Then, floating cells
become cytotoxic and die.
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Figure 2.1
Crocidolite-Induced Cytotoxicity in Lung Epithelial Cells Dose Response
(N=3-6)
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*p<0.05, **p<0.01

Crocidolite Dose (µg/cm2)
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Crocidolite was added to a final dose of 5, 10, or 20 µg/cm2 per well. After 24
hours of exposure, viability was measured using CellTiter96 Aqueous One Solution
Reagent (Promega) as described in Methods section. Values were normalized considering
that cells exposed to media only have 100% of viability.
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Figure 2.2
LA-4 cells Lactate Dehydrogenase (LDH) Release after Crocidolite Exposure
(N=3)
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Treatment Groups
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Crocidolite was added to a final dose of 20 µg/cm2 per well. After 24 hours of
exposure, cytotoxicity was approached detecting LDH release using Cytotoxic Detection
Assay (LDH) (Roche Applied Sciences) as described in Methods section. Values were
normalized considering that cells exposed to media only have no LDH release and cells
exposed to Triton X-100 have 100% of LDH release.
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Figure 2.3
6-keto PGF1α Production in LA-4 Cells After Crocidolite Exposure
(N=3)
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Treatment Groups
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Crocidolite was added to a final dose 10 µg/cm2 per well. After 24 hours of
exposure, 6-keto PGF1α release was measured using ACE Competitive Enzyme
Immunoassay (Cayman Chemical) as described in Methods section. Values were
normalized considering that cells exposed to media only have 100% of 6-keto PGF1α
release.
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Figure 2.4

Relative production of 6-keto PGF1 alpha (%)

6-keto PGF1α Production in LA-4 Cells After Crocidolite Exposure (10
µg/cm2) in the Presence of COX inhibitors
(N=2-3)
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Treatment Groups
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. The Cox 1/2 inhibitor Indomethacin and the specific Cox 2 inhibitor Indomethacin
heptyl ester were added at a dose 10 times their respective IC50 (inhibitory concentration
of 50% of the total activity) simultaneously with crocidolite (10 µg/cm2 per well). After
24 hours of exposure, 6-keto PGF1α release was measured using ACE Competitive
Enzyme Immunoassay (Cayman Chemical) as described in Methods section. Values were
normalized considering that cells exposed to media only have 100% of 6-keto PGF1α
release.
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Figure 2.5
Cyclooxygenase 2 mRNA Expression After Crocidolite Exposure (10 µg/cm2)
(N=3)
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Hours After Crocidolite Exposure
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Crocidolite was added to a final dose 10 µg/cm2 per well. After 2 and 4 hours of
crocidolite exposure, cells were lysed and total RNA isolated using Trizol reagent
(Invitrogen). First strand reverse transcription was performed with oligo dT and
amplification done using Platinum Quantitative PCR SuperMix-UDG (Invitrogen). Ct
values were recorded and Cox 2 data analyzed relative to GAPDH.
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Figure 2.6
Crocidolite-Induced Cytotoxicity in the Presence of the COX 1/2 Inhibitor
Indomethacin
(N=3)
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Crocidolite Dose (µg/cm2)
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. The Cox 1/2 inhibitor Indomethacin was added at doses 10 and 100 times its IC50
simultaneously with crocidolite (5, 10, 20 µg/cm2 per well). After 24 hours of exposure,
viability was measured using CellTiter96 Aqueous One Solution Reagent (Promega) as
described in Methods section. Values were normalized. Media only exposed cells were
considered to have 100% of viability.
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Figure 2.7
Crocidolite-Induced Cytotoxicity in the Presence of the COX 2 Inhibitor
Indomethacin Heptyl Ester
(N=3)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. The specific Cox 2 inhibitor Indomethacin heptyl ester was added at doses 10 and
100 times its IC50 simultaneously with crocidolite (5, 10, 20 µg/cm2 per well). After 24
hours of exposure, viability was measured using CellTiter96 Aqueous One Solution
Reagent (Promega) as described in Methods section. Values were normalized. Media
only exposed cells were considered to have 100% of viability.
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Figure 2.8
Integrin Vitronectin Receptor Expression in LA-4 cells

Three hundred thousand LA-4 cells were labeled with anti-alpha-v (CD51) fluorescent
labeled antibody. After 20 minutes incubation at 4ºC, fluorescence was detected on a
FACs Aria Flow cytometer using FACs Diva software (Becton Dickson). Hoechst 33258
dye (Invitrogen) was added to a final concentration of 1 µg/ml in order to exclude dead
cells. Results shown are representative of three experiments.
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Figure 2.9
Integrin Vitronectin Receptor in LA-4 cells
(N=3)
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Three hundred thousand LA-4 cells were labeled with anti-alpha-v fluorescent labeled
antibody. After 20 minutes incubation at 4ºC, fluorescence was detected on a FACs Aria
Flow cytometer using FACs Diva software (Becton Dickson). Hoechst 33258 dye
(Invitrogen) was added to a final concentration of 1 µg/ml in order to exclude dead cells.
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Figure 2.10

Relative production of 6-keto PGF1 alpha (%)

6-keto PGF1α Production in LA-4 Cells After Crocidolite Exposure (20
µg/cm2) in the Presence of RGDS peptide inhibitor
(N=3)
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Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. RGDS peptide (a VNR inhibitor) or RGES peptide (non-specific binding control)
at a final dose of 10 µg/ml were added simultaneously with crocidolite (20 µg/cm2 per
well). After 24 hours of exposure, 6-keto PGF1α release was measured using ACE
Competitive Enzyme Immunoassay (Cayman Chemical) as described in Methods section.
Values were normalized considering that cells exposed to crocidolite with no inhibitor
have 100% of 6-keto PGF1α release.
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Figure 2.11

Relative production of 6-keto PGF1 alpha (%)

6-keto PGF1α Production in LA-4 Cells After Crocidolite Exposure (20
µg/cm2) in the Presence of RMV-7 VNR inhibitor
(N=3)
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Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. RMV-7 blocking antibody (anti-alpha-v) was added at a final dose of 2 µg/ml one
hour before crocidolite exposure (20 µg/cm2 per well). After 24 hours of exposure, 6-keto
PGF1α release was measured using ACE Competitive Enzyme Immunoassay (Cayman
Chemical) as described in Methods section. Values were normalized considering that
cells exposed to crocidolite with no inhibitor have 100% of 6-keto PGF1α release.
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Figure 2.12

Relative production of 6-keto PGF1 alpha (%)

6-keto PGF1α Production in LA-4 Cells After Crocidolite Exposure in the
Presence of BALF
(N=3)
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Crocidolite Dose (µg/cm2)
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Then media was changed for Opti-mem I reduced serum medium (Mediatech Inc.)
and BALF added to a final concentration of 25% with crocidolite (10 and 15 µg/cm2 per
well). After 24 hours of exposure, 6-keto PGF1α release was measured using ACE
Competitive Enzyme Immunoassay (Cayman Chemical) as described in Methods section.
Values were normalized considering that cells no exposed to crocidolite have 100% of 6keto PGF1α release.
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Figure 2.13
Crocidolite-Induced Cytotoxicity in the Presence of Reduced Serum Media
and BALF
(N=3)
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Crocidolite Dose (µg/cm2)
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Then media was changed for Opti-mem I reduced serum medium (Mediatech Inc.)
and BALF added to a final concentration of 25% with crocidolite (10 and 15 µg/cm2 per
well). After 24 hours of exposure, viability was measured using CellTiter96 Aqueous
One Solution Reagent (Promega) as described in Methods section. Values were
normalized considering that cells exposed to media only have 100% of viability.
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Figure 2.14
Crocidolite-Induced Cytotoxicity in the Presence of RGDS Peptide Inhibitor
(N=3)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. RGDS peptide (a VNR inhibitor) or RGES peptide (non-specific binding control)
at a final dose of 10 and 100 µg/ml were added simultaneously with crocidolite (5, 10, 20
µg/cm2 per well). After 24 hours of exposure, viability was measured using CellTiter96
Aqueous One Solution Reagent (Promega) as described in Methods section. Values were
normalized considering that cells exposed to media only have 100% of viability.

76

Figure 2.15
LA-4 cells LDH Release after Crocidolite Exposure (20 µg/cm2) in the
Presence of RMV-7 VNR Inhibitor
(N=3)
140.0
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Cytotoxicity (%)
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Control

Crocidolite

Triton X-100

Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. RMV-7 blocking antibody (anti-alpha-v) was added at a final dose of 2 µg/ml one
hour before crocidolite exposure (20 µg/cm2 per well). After 24 hours of exposure,
cytotoxicity was approached detecting LDH release using Cytotoxic Detection Assay
(LDH) (Roche Applied Sciences) as described in Methods section. Values were
normalized considering that cells exposed to media only have no LDH release and cells
exposed to Triton X-100 have 100% of LDH release.
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Figure 2.16
Floating LA-4 Cells After Crocidolite Exposure (20 µg/cm2)
(N=3)
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*p<0.05

Media

Crocidolite

Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at one million cells in a 25
cm2 flask. Then Crocidolite was added to a final dose of 20 µg/cm2. After 24 hours of
exposure, floating cells were collected from media, and counted by hemocytometer.
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Figure 2.17
Floating LA-4 Cells Viability After Crocidolite Exposure (20 µg/cm2)
(N=3)
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Media

Crocidolite

Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at one million cells in a 25
cm2 flask. Then Crocidolite was added to a final dose of 20 µg/cm2. After 24 hours of
exposure, floating cells were collected from media. Then, a sample from each group was
taken and stained with Trypan Blue in a 1:1 dilution. Cells excluding the dye were
considered viable.
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Figure 2.18
Floating LA-4 Cell Count After Crocidolite Exposure (20 µg/cm2) in the
Presence of RMV-7 VNR Inhibitor
(N=3)
120%

Cell Number Change (%)
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Cro

Cro+RMV-7

Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at one million cells in a 25
cm2 flask. One hour before exposure RMV-7 antibody was added at a final concentration
of 1.5 µg/ml. Then Crocidolite was added to a final dose of 20 µg/cm2. After 24 hours of
exposure, floating cells were collected from media, and counted by hemocytometer.
Values were normalized with their respective control (media only, and media with RMV7). The group exposed to crocidolite without RMV-7 was considered to have 100% of
floating cells.
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Figure 2.19
Floating LA-4 Cells Viability After Crocidolite Exposure (20 µg/cm2) in the
Presence of RMV-7 VNR inhibitor
(N=3)
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Crocidolite

Cro + RMV-7

Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at one million cells in a 25
cm2 flask. One hour before exposure RMV-7 antibody was added at a final concentration
of 1.5 µg/ml. Then Crocidolite was added to a final dose of 20 µg/cm2. After 24 hours of
exposure, floating cells were collected from media. Then, a sample from each group was
taken and stained with Trypan Blue in a 1:1 dilution. Cells excluding the dye were
considered viable. Ratios were calculated with their respective control (media only, and
media with RMV-7).
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Figure 2.20
Floating LA-4 Cells Absolute Numbers and Viability After Crocidolite
Exposure (20 µg/cm2)
(N=3)
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Cro+RMV-7

Treatment Group
Cells were trypsinized and plated 24 hours prior to exposure at one million cells in a 25
cm2 flask. One hour before exposure RMV-7 antibody was added at a final concentration
of 1.5 µg/ml. Then Crocidolite was added to a final dose of 20 µg/cm2. After 24 hours of
exposure, floating cells were collected from media, and counted by hemocytometer.
Then, a sample from each group was taken and stained with Trypan Blue in a 1:1
dilution. Cells excluding the dye were considered viable. Absolute cell count numbers
were calculated using total cell count number and percentage of viable cells.
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Figure 2.21
Proposed Model for Crocidolite Induced Response in Alveolar Type II Cells
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First, an RGD protein present in fetal bovine serum and BALF coats crocidolite and
binds VNR. This interaction will induce Cox 2 expression and activity promoting
prostacyclin biosynthesis. Second, crocidolite also induces cytotoxicity independently
from RGD protein, VNR, Cox 1 or Cox 2. And third, cells bind RGD coated crocidolite
fibers through VNR and detach from the bottom of the flask forming floating clusters of
cells attached to crocidolite fibers. Then, floating cells become cytotoxic and die
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Chapter 3
Role of Scavenger Receptors in Silica Binding and
Apoptosis
Silicosis is the ILD produced by the inhalation of silica particles. ILD are a large
and heterogeneous group of lower respiratory tract disorders, also known as “Interstitital
pulmonary fibrosis” or “Diffuse parenchymal lung disease.” Silica particles, after
reaching the alveoli, are phagocytosed by the resident alveolar macrophages (AM).
Macrophages containing silica undergo apoptosis releasing the particles that will be taken
up by other AMs. This permanent cycle of phagocytosis-apoptosis contributes to the
induction of ILD (Wang, Antonini et al., 2003; Wang, Scabilloni et al., 2005). The
macrophage scavenger receptor A (SR-A or CD204) is a pattern recognition receptor able
to interact with multiple ligands with different levels of affinity. It has been reported that
SR-A has an important role in the process of silica-induced apoptosis, but the mechanism
is still unknown (Chao, Hamilton et al., 2001; R. F. Hamilton, de Villiers et al., 2000; R.
F. Hamilton, Iyer et al., 1996; Iyer, Hamilton et al., 1996)
Structurally SR-AII is a trimeric transmembrane protein that contains five
domains: 1) cytoplasmic, 2) transmembrane domain, 3) spacer, 4) α-helical coiled-coiled,
and 5) collagenous domain. SR-AI contains an additional 6th domain called cysteine-rich
(SRCR) (Kodama, Freeman et al., 1990). The role of the cytoplasmic domain in surface
expression and modified LDL internalization had been previously described (Kosswig,
Rice et al., 2003; Morimoto, Wada et al., 1999). The cytoplasmic region of SR-AI and II
contains twelve amino acids that could be phosphorylated (Ser and Thr). Four of these
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amino acids are common in the SR-A sequence of five different mammalian species.
These amino acids correspond to Ser25, Ser32, Ser53, and Thr34 in the SR-A mouse
sequence. Based on this information, it is possible that these four amino acids play an
important role in SR-A signaling.
As mentioned above, the key difference between SR-AI and SR-AII is that SR-AI
contains a SRCR. Previous studies comparing SR-AI and SR-AII binding properties were
performed using modified LDL as ligands, showing no difference in polyanion binding
specificity between both SR-As. Since there are no studies evaluating the role of the SRA cytoplasmic domain in the silica-induced apoptosis or comparing binding properties
between SR-AI and SR-AII using silica as a particulate ligand, we generated the
following general hypothesis:

Hypothesis
“Silica binding to SR-A results in an induction of apoptosis mediated by a signal
transduction mechanism beginning at specific cytoplasmic domains, and the presence of
the SCRC domain in SR-AI increases the binding efficiency of silica.”

Aims
I.

Evaluate the effect of transfected wild type CD204 in CHO cells (null for
CD204).

II.

Identify which amino acids (Ser or Thr) in the cytoplasmic domain of CD204 are
responsible for the induction of apoptosis.
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III.

Evaluate the role of SRCR domain by comparing SR-AI and SR-AII containing
clones in their response to silica.
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Aim I. Evaluate the effect of transfected wild type CD204 in CHO
cells (null for CD204)
It has been previously described that CHO cells normally null for SR-AII become
apoptotic after silica exposure when they express SR-AII (R. F. Hamilton, de Villiers et
al., 2000). In this aim a SR-AII construct was developed and CHO cells were stably
transfected in order to generate CHO cells expressing SR-AII as previously described in
the Hamilton et al. paper. Stably SR-AII transfected cells were used as a positive control
in further studies to evaluate silica-induced apoptosis. After generating the stably SR-AII
CHO transfected cell line their functionality was examined by measuring binding and
uptake of AcLDL, and apoptosis following silica exposure

a. Induce expression of CD204 in CHO cells.
b. Evaluate functionality of the CHO-CD204 transfected cells.
c. Determine apoptosis induced by silica in CHO-CD204 transfected cells.
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Aim I.a. Induce expression of CD204 in CHO cells.
After generating the SR-A constructs, stable CHO cell lines expressing SR-AII
were developed by transfecting CHO cells with the constructs.

Methods
Cell Culture
Chinese Hamster Ovarian cells CHO-K1 cells (ATCC, Manassas, VA) were
maintained in Ham's F12K medium (Mediatech, Inc.) supplemented with 2 mM Lglutamine adjusted to contain 100 units/ml of penicillin, 100 µg/ml streptomycin, 0.25
µg/ml amphotericin B (Mediatech, Inc.), and 10% fetal bovine serum (Hyclone). Cell
cultures were incubated at a temperature of 37ºC in an atmosphere of 95% air and 5%
CO2 (ThermoForma).

Plasmid Constructs
Mammalian expression vectors pcDNA3.1(+) Hygro and pcDNA3.1/myc-His-A
(Figure 3.1) were purchased from Invitrogen. The murine SR-AII cDNA used was
obtained from Invitrogen NIH Mammalian Gene Collection full-length (IRAV), clone ID
3594142 Mus musculus macrophage scavenger receptor 1 cDNA, which was inserted
into a pCMV-SPORT6 vector. The following procedures were performed in order to
subclone the SR-AII cDNA into the pcDNA3.1(+) Hygro vector. The restriction sites
KpnI and XbaI were identified in the SR-AII cDNA at the 5’ and 3’ terminus
respectively. In order to use the pcDNA3.1/myc-His-A vector, a mutation of the stop
codon was required to achieve the expression of the myc epitope and 6X His tag
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contained in the vector. The forward primer containing a KpnI restriction site 5’-GCT
GCT GGT ACC ACG CGT CCG ATA AAT CAG TGC TGT-3’, and the reverse primer
containing an XbaI restriction site and a mutation of the stop codon 5’-GCT GCT TCT
AGA GGG TAC TGA TCT TGA TCC GCC TAC-3’ were used. PCR was run using
these primers and Pfu DNA polymerase from Stratagene (La Jolla, CA). PCR products
and vectors were digested with KpnI and XbaI, and ligated with T4 DNA Ligase from
Promega (Madison, WI). All constructs were verified by restriction map and sequencing.
Sequences were compared with the GenBank Mus musculus macrophage scavenger
receptor 1, mRNA (cDNA clone MGC:6140 IMAGE:3594142), accession number
BC003814.1.

Transfection
The following constructs were transfected in CHO cells separately: EVh
(pcDNA3.1(+) Hygro), EVn (pcDNA3.1/myc-His-A), SRA-IIh (pcDNA3.1(+) Hygro +
SR-AII), and SR-AIIn (pcDNA3.1/myc-His-A + SR-AII). Lipofectamine 2000
Transfection Reagent (Invitrogen) was used for CHO cell transfection following
manufacturer’s instructions. Briefly, 24 hours before transfection CHO cells were plated
in 24-well plates at 1.2 x 105 cell per well in 0.5 ml of antibiotic free medium. Then 0.8
µg of vector DNA and 2.5 µl of transfection reagent were diluted in separate tubes with
50 µ l of Opti-mem I reduced serum medium (Invitrogen). After five minutes of
incubation at room temperature both solutions were combined and re-incubated at room
temperature for 20 additional minutes. The combined solution was then added directly to
the well containing CHO cells and mixed. Cells were incubated at the conditions
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previously mentioned and growth medium was changed after 4 hours. Forty-eight hours
after transfection, Geneticin or Hygromycin antibiotic (Invitrogen) was added at a final
concentration of 500 or 700 µg/ml respectively, for antibiotic selection of transfected
cells. Successful clones were isolated and characterized.

Confirmation of Genomic Incorporation
Genomic DNA was isolated from one to two million transfected cells with the
DNeasy Blood & Tissue Kit from Qiagen Inc. (Valencia, CA). Isolated genomic DNA
was amplified using T7 as sense primer (present only in the vector) and as antisense the
SR-AII primer 5’-CCT CCA TGT CCT TCA TGT GTG- 3’. PCR was run using Pfu
DNA polymerase from Stratagene.

Immunoprecipitation and Western Blot
Cells were cultured on 75 cm2 flasks. After scraping, ten million cells were
incubated on ice for 30 min in 200 µl of lysis buffer as previously described (R. F.
Hamilton, de Villiers et al., 2000). Rat anti mouse CD204 antibody (2F8) from Serotec
(Oxford, UK) was added to reach a final dilution of 1:40, and incubated overnight at 4°C
in an end-over-end rotator. Thereafter 30 µl of Protein G-agarose from Roche Applied
Science (Indianapolis, IN) was added and incubated under the same conditions overnight.
The lysate containing the antibodies and protein G-agarose was washed three times and
30 µl of Laemmli sample buffer containing 5% beta mercaptoethanol was added. CD204
immunoprecipitated cell lysate was incubated at 70°C for ten minutes, loaded in a 4-15%
linear gradient Ready Gel Tris-HCl gel from Bio-Rad (Hercules, CA), and
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electrophoresed for 1 hour at 100 volts. Proteins were electrophoretically transferred to a
Trans-Blot Transfer medium nitrocellulose membrane (Bio-Rad) for 1.5 hrs at 100 volts
and blocked for 1 hour at room temperature with buffer containing non-fat milk dry 5%.
Primary monoclonal anti-6X His tag antibody from Abcam (Cambridge, MA) was added
to reach at a final dilution of 1:5000, and incubated overnight at 4°C. Nitrocellulose
membranes were washed 3 times for 5 minutes each and exposed to horseradish
peroxidase conjugated anti-rabbit IgG antibody from Cell Signaling Technology
(Danvers, MA) for 1h at room temperature. Enhanced chemiluminescence (ECL)
development was performed with ECL western blotting detection reagents from
Amersham Biosciences (Piscataway, NJ) according to manufacturer’s instructions.
Images were taken using a Versadoc Imaging System 3000 (Bio-Rad).

Results
In order to establish a transfection control for future comparisons, constructs
containing the mammalian expression vectors pcDNA3.1(+) Hygro or pcDNA3.1/mycHis-A only were used and named empty vector (EV) EVh or EVn respectively.
Constructs generated with SR-AII were named SR-AIIh or SR-AIIn as for EVs.
Restriction mapping was performed with the enzyme Sca I on both constructs to verify
the final product containing SR-AII. Figures 3.2 and 3.3 show the presence of the SR-AII
in both constructs. Sequence results were confirmatory of SR-AII cDNA sequence (data
not shown). After transfection, SR-AIIh incorporation in CHO cell genome was verified
by the presence of a PCR product of around 500 base pairs (Figure 3.4). Protein
expression was confirmed in cells transfected with SR-AIIn by IP and WB due to the
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presence of 6X-His tag (Figure 3.5). SRA-IIn monomer has a molecular weight of
approximately 75 kDa, the MW of the band shown in Figure 3.5. Also a band of
approximately 60 kDa could be seen in each of the different groups of cells. This band
could be the result of some non-specific binding by the heavy chain of the anti-CD204
IgG used for IP. The presence of the 75 kDa band not only confirmed the expression of
SRA-II, but also demonstrated that the full length of the SRA-II including the 6X His tag
was expressed. After verifying SR-AII protein expression, SR-AII surface functionality
was evaluated in the SR-AII transfected CHO cells.
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Aim I.b. Evaluate functionality of CD204 in CHO transfected
cells.
Total SR-A expression was verified previously by IP, but not SR-A expression on
the cell surface. This aim looked for a better approach of determining SR-A functionality
on the surface of transfected CHO cells using different techniques such as AcLDL uptake
and silica binding in order to verify SR-A surface expression.

Methods
Acetylated Low Density Lipoproteins (AcLDL) Uptake
Cells were plated in a Lab-Tek II eight-well chamber slide from Nalge Nunc
International (Rochester, NY) at 5x104 cells per well 24 hours before exposure. When SR
blocking ligands were used, cells were pre-treated with Polyinosinic acid (PolyI) from
Sigma-Aldrich (St. Louis, MO) at 100 µg/ml or anti CD204 blocking antibody 2F8
(Serotec) at 1 µg/ml for 30 minutes as previously reported (Obot et al., 2002). Alexa
Fluor 488 conjugated AcLDL (Invitrogen) was then added to the cells at a final
concentration of 10 µg/ml and incubated for 90 minutes at 37ºC. After incubation
medium was removed, cells were fixed with 3% paraformaldehyde in PBS, incubated for
20 minutes at room temperature, and washed four times with PBS as reported by
DiDonato et al., for the study of lipid droplets (DiDonato & Brasaemle, 2003). Nuclei
staining with propidium iodide (PI) was performed for cell detection. PI was added at a
final concentration of 500 ng/ml, incubated for 5 min at room temperature and washed
three times with PBS. Images were taken at 400x magnification with a Zeiss Axioskop
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Fluorescence Microscope using a FITC/GFP filter (blue light) for Alexa Fluor 488 and
Rhodamine/Texas Red filter (green light) for PI. Confocal microscopy pictures were
taken at 1000x magnification with a Radiance 2000 Laser Scanning System (BioRad)
attached to a Nikon Eclipse TE300 microscope. Images were processed with Adobe
Photoshop version 7.0.1 and ImageJ version 1.35q. For fluorescence quantification, slides
were scanned using a Laser Scanning Cytometer (LSC) with a 20x objective. Cells were
detected by contouring around nucleic acid PI stain and data was analyzed with WinCyte
LSC software V3.6 from CompuCyte Corporation.

Silica Exposure
Crystalline silica (min-U-sil-5) 1-5 µm diameter from Pennsylvania Sand Glass
Corp. (Pittsburgh, PA) was initially acid washed in 1M HCl at 100ºC, washed in sterile
water three times and dried at 200ºC. Silica suspension (40 mg/ml) was freshly made by
mixing in pure water. The suspension was sonicated using a Sonicator Ultrasonic
processor XL (Misonix) for one minute, mixed with fresh cell culture media and added to
the cell cultures.

Quantification of Silica Binding and/or Uptake
One million cells were exposed to silica at a concentration of 150 µg/ml in an
end-over-end rotator for 90 minutes at 37ºC. Silica binding/uptake was quantified by
evaluating cell granularity as measured by flow cytometric right angle scatter (RAS),
which correlates with particle binding/uptake (Palecanda & Kobzik, 2000).
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Statistical Analysis
Results were presented as the mean and SEM unless indicated. When required
data was normalized with its respective control in order to exclude differences in
background conditions. Data was analyzed using Student T test for independent
variables, paired T test, ANOVA, or nonparametric statistics (Mann-Whitney U test was
used when comparing two groups, and Kruskal-Wallis test when comparing three groups
or more). Statistics analyses were performed using the software GB-Stat version 6.5.6.
Alpha error was set at p<0.05.

Results
In order to verify functional surface expression of SR-AII on CHO transfected
cells fluorescent microscopy studies were performed. Cells transfected with each
construct (SR-AIIh or SR-AIIn) internalized fluorescent labeled AcLDL. This was
verified by co-localization of the Alexa488 labeled AcLDL with the PI labeled cells
using the fluorescence microscope (Figures 3.6 and 3.7). Fluorescence quantification of
the Alexa488 labeled AcLDL in the cells using the LSC confirmed the observations of
the fluorescence microscope due to an increase in fluorescence in the cells transfected
with SR-AII. Because AcLDL have been internalized by SR-AII receptors and SR-AII
receptors needed to be on the cell surface in order to bind and internalize AcLDL, these
results strongly support the idea that functional SR-AIIh and SR-AIIn are expressed on
the cell surface. (Figures 3.8 and 3.9). In order to verify if the increase of AcLDL uptake
was specific for SR-AII expression, SR-AII blocking ligands 2F8 (CD204 specific) and
PolyI (broad unspecific scavenger receptor ligand) were used in each transfected SR-AII
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construct. Figures 3.10 and 3.11 show the results of these experiments in percentage.
Fluorescence values within each experiment were very different, but the blocking
antibody 2F8 decreased the uptake of AcLDL in every experiment. Due to the difference
in fluorescence among experiments, paired T tests were performed between the group
with AcLDL and each groups with inhibitors. A statistically significant decrease in
AcLDL uptake was found in each group that received SR-AII inhibitors. This indicated
that AcLDL uptake was SR-AII specific. After verifying SR-A functionality, some
preliminary silica binding studies were performed. Several attempts were performed in
order to detect silica binding/uptake by side scatter (granularity) in SR-AII transfected
CHO cells. Figures 3.12, 3.13, and 3.14 show these results with each construct (SR-AIIh
and SR-AIIn). In every experiment run, side scatter apparently was higher in the control
groups (EVh or EVn) than in the SR-AII transfected groups. All these finding show that
SR-AII is functional on the cell surface of transfected CHO cells due to the increase in
AcLDL uptake. Unfortunately the same transfectants did not bind/uptake silica
(evaluated by side scatter) in any of the three experiments run. On the contrary SR-AII
transfectants exposed to silica showed less granularity than exposed controls. Because
silica interaction with SR-AII induces apoptosis (R. F. Hamilton, de Villiers et al., 2000)
the next aim evaluated silica SR-AII interaction by apoptosis detection.
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Aim I.c. Determine apoptosis induced by silica in CHO-CD204
transfected cells.
Stable transfected CHO cells expressing functional SR-A were exposed to silica
in order to induce apoptosis as previously reported. Apoptosis detection was performed
using different methods previously reported (Lecoeur, 2002; Lovborg et al., 2005;
Plaetzer et al., 2005).

Methods
Apoptosis Assays
TiterTACS: Apoptosis detection was performed by in situ detection of DNA
fragmentation in immobilized cells. TiterTACS (R&D systems, Minneapolis, MN) labels
fragmented DNA allowing colorimetric detection of apoptotic cells. Cells were scraped
and plated 24 hours prior to exposure at 2 x105 cell in a volume of 200 µl per well in a 96
well plate. Cell culture media was changed at exposure time. Silica was added to a final
concentration of 66.7 µg/cm2. Cells were exposed to silica for 24 hours before performing
any assessment. After fixing the cells, TiterTACS was used to detect DNA fragmentation
according to manufacturer’s assay protocol. Absorbance at 450 nm was measured.
Caspase-3 Activity Assay for High Throughput Screening (HTS): Caspase 3 is a terminal
caspase activated during apoptosis and can serve as an assay for undergoing apoptosis.
After apoptotic stimuli cells activate Caspase-3. Activated Caspase-3 specifically cleaves
after the aspartate residues in the DEVD peptide sequence. Detection of the cleavage of a
fluorescent labeled DEVD containing substrate can be achieved by monitoring the shift in
fluorescence. Caspase-3 Activity Assay for HTS was purchased from Calbiochem (EMD,
97

San Diego, CA). Cells were scraped and plated 24 hours prior to exposure at 2 x105 cell
in a volume of 100 µl per well in a 96 well plate. Cell culture media was changed at
exposure time. Silica was added to a final concentration of 50 µg/cm2 and cells were
exposed to silica for 24 hours before performing any assessment. Caspase-3 activity was
detected according to manufacturer’s assay protocol. Fluorescence was detected at an
excitation wavelength of 400 nm and emission wavelength of 505 nm.
Tunel Assay (Terminal Deoxynucleotide Transferase dUTP Nick End Labeling): As
previously described, apoptotic cells degrade their nuclear DNA into fragments, and its
detection allows the identification of apoptotic cells. Cells were scraped and 1.5 x 106
cells were transfered to 25 cm2 flasks and preincubated for 48 hours. Silica was added at
a final concentration of 50 µg/cm2. After 24 hour-exposure cells were trypsinized,
washed and transferred to fresh tubes for DNA labeling. APO-BrdU TUNEL Assay Kit
from Invitrogen was purchased. Cells were fixed and stained following manufacturer’s
assay protocol. Samples were analyzed by flow cytometry.

Cell Cytotoxicity Assays
Viability Assay: Cells were scraped and plated 24 hours prior to exposure at 50,000 cells
in a volume of 200 µl per well in a 96 well plate. Cell culture media was changed at
exposure time. Silica was added to final concentrations of 25, 50, and 100 µg/cm2. Cells
were exposed to silica for 24 hours before performing any assessment. After exposure, a
volume of 100 µl of media was removed leaving 100 µl of media in each well. Twenty µl
of CellTiter96 AQueous One Solution Reagent from Promega (Madison, WI) was added
into each well and incubated for 1-4 hours at 37ºC in a humidified 5% CO2 atmosphere.
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Optical density (OD) was measured using a microplate reader (Molecular Devices,
Sunnyvale, CA) at a wavelength of 490 and for reference at 650 nm. For normalizing,
each control group (non-exposed) was considered to have 100% viability.
Cytotoxicity Assay: LDH release was measured using the Cytotoxicity Detection Assay
(LDH) (Roche Applied Science, Indianapolis, IN). Cells were scraped and plated 24
hours before exposure as previously described. At exposure time, cell culture media was
replaced with 1% FBS in order to decrease the LDH background absorbance, as
recommended by manufacturer. Triton X-100 (Sigma-Aldrich Inc., St Louis, MO) at 1%
was used as a positive control. After exposure 100 µl of cell culture media was
transferred to a 96-well plate, mixed with 100 µl of reaction mixture, and incubated for
30 minutes at room temperature protected from light. OD was measured at a wavelength
of 492 and 650 nm. Cytotoxicity was calculated as a percentage between minimum or 0%
(non-exposed) and maximum or 100% (Triton X-100) control values.

Data was analyzed as previously described in Aim I.b.

Results
DNA fragmentation, a marker of apoptosis, was approximated using TiterTACS
in SR-AIIn transfected cells exposed to 66.7 µg/cm2 of silica. A slight, but not
statistically significant increase in DNA fragmentation was observed (Figure 3.15).
Caspase-3 activity, a second different method for the detection of apoptosis, was used.
Silica exposure of at a dose of 50 µg/cm2 did not increase caspase-3 activity in SR-AIIn
transfected CHO cells in comparison with its transfected EVn control (Figure 3.16).
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TUNEL assay detected by flow cytometry was performed in SR-AIIh transfected CHO
cells after being exposed to silica 50 µg/cm2. No difference was found between SR-AIIh
and its respective transfected control (Figure 3.17).
Because apoptosis could not be consistently detected using several known
techniques, cell cytotoxicity assays were performed in order to verify if silica is toxic to
CHO transfected cells. CHO cells transfected with either SR-AIIh or SR-AIIn constructs
did not show significant differences in LDH release in comparison with its respective
transfection control when increasing silica doses of 25, 50, and 100 µg/cm2 were used
(Figures 3.18 and 3.19). Viability of CHO cells transfected with SR-AIIh was not
different from its respective control when exposed to the same increasing silica doses of
25, 50, and 100 (Figure 3.20). However, it was observed that increasing doses of silica
were similarly toxic in SR-AII and their respective transfection control. In order to
determine if any kind of SR could be responsible for this silica-induced toxicity, SR-AII
inhibitors were preincubated for 30 minutes before adding a silica dose of 50 µg/cm2. The
use of SR-A inhibitors 2F8 and PolyI did not decrease the release of LDH after silica
exposure in any of the CHO transfected cells groups suggesting no SR-A involvement in
silica-induced cytotoxicity (Figure 3.21).
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Aim II. Identify which amino acids (Ser or Thr) in the cytoplasmic
domain of CD204 are responsible for the induction of apoptosis.

The cytoplasmic region of SR-AI and II contains twelve amino acids that could be
phosphorylated (Ser and Thr). Four of these amino acids are common in the SR-A
sequence of five different mammal species. These amino acids correspond to Ser25,
Ser32, Ser53, and Thr34 in the SR-A mouse sequence. In this study, this aim was carried
out simultaneously with aim I evaluating the role of different constructs in silica-induced
apoptosis.

a. Induce mutations in phosphorylation sites Ser 25, Ser 32, Thr 34, and Ser 53.
b. Induce apoptosis with silica in CHO cells transfected with each mutated CD204, and
evaluate if apoptosis is inhibited or increased with each specific mutation.
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Aim II.a. Induce mutations in potential phosphorylation sites Ser
25, Ser 32, Thr 34, and Ser 53.
SR-AI/II cDNA sequences corresponding to the cytoplasmic domain of five
different species (human, mouse, bovine, dog, and rabbit) were aligned and a consensus
of four Ser/Thr amino acids was found. Separate constructs expressing mutations in these
cytoplasmic Ser/Thr. A fifth mutation affecting the extracellular lysine cluster, which is
necessary for AcLDL binding (Andersson & Freeman, 1998; Doi, Higashino et al.,
1993), was generated in order to verify if the lysine cluster was also necessary for silica
binding.

Methods
Mutations
Mutations of the SR-AII Serines 25, 32, 53, Threonine 34, and Lysines 339-342 were
performed separately. The constructs SR-AIIh and SR-AIIn were mutated using the
QuikChange site-directed mutagenesis kit (Stratagene) following manufacturer’s
recommendations. The following primers (5’ to 3’) were designed to introduce those
mutations:
1) S25A
a. sense TGA CTG CAG TTC AGA AGC CGT GAA ATT TGA CGC AC
b. antisense GTG CGT CAA ATT TCA CGG CTT CTG AAC TGC AGT CA
2) S32A
a. sense TGA AAT TTG ACG CAC GTG CCA TGA CAG CAT CCC TTC C
b. antisense GGA AGG GAT GCT GTC ATG GCA CGT GCG TCA AAT TTC A
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3) S53A
a. sense GGA GAA GTT GAA GGC CTT CAA GGC TGC CC
b. antisense GGG CAG CCT TGA AGG CCT TCA ACT TCT CC
4) T34A
a. sense CGC ACG TTC AAT GGC AGC ATC CCT TCC TC
b. antisense GAG GAA GGG ATG CTG CCA TTG AAC GTG CG.
5) K-E
a. sense GGA TCT CCT GGA CCT GAA GGA CAA GAG GGA GAG AAG G
b. antisense CCT TCT CTC CCT CTT GTC CTT CAG GTC CAG GAG ATC C.

Once each mutated SR-AII was generated, DH5α cells (Invitrogen) were
transformed with each mutated construct. After verifying each mutated construct by DNA
sequencing, CHO cells were transfected with each construct separately using
Lipofectamine 2000 Transfection Reagent (Invitrogen) as previously described in Aim
I.a. Forty-eight hours after transfection Geneticin or Hygromycin antibiotic (Invitrogen)
was added at a final concentration of 500 and 700 µg/ml respectively, for antibiotic
selection of transfected cells for 15 days. Successful clones were isolated and
characterized. Protein expression was confirmed by IP as described in Aim I.a., and
functionality by AcLDL uptake as described in Aim I.b.

Data was analyzed and presented as previously described in Aim 1.b.
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Results
Constructs expressing mutated CD204 were isolated and verified by DNA
sequencing (Figure 3.22). Protein expression of mutated CD204 were evaluated by IP and
WB, which showed a band of approximately 75 kDa confirming the expression of the
mutated SRA-II proteins (Figure 3.23). A second IP and WB was performed 4 weeks
after the first one. Results were non consistent with previous findings showing increase or
decrease on protein expression in the different mutations after 4 weeks (data not shown).
In addition, it was not possible to determine surface expression of SR-AII due to the low
affinity of the SR-AI/II antibody.
AcLDL uptake was quantified as previously described in Aim I.b. using the LSC
(Figure 3.24). All of the transfectants expressing mutated cytoplasmic domain were able
to internalize AcLDL, with no statistical difference between any of them and normal SRAII. As expected, the K-En mutant did not bind AcLDL due to the lack of lysine cluster
necessary for this function.
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Aim II.b. Induce apoptosis with silica in CHO cells transfected
with each mutated CD204, and evaluate if apoptosis is inhibited
or increased with each specific mutation.
After verifying mutated SR-AII constructs expression and functionality by
AcLDL uptake, silica-induced apoptosis was evaluated in all constructs to determine their
role inducing apoptosis.

Methods
TiterTACS: Apoptosis detection was performed by in situ detection of DNA
fragmentation in immobilized cells. TiterTACS (R&D systems, Minneapolis, MN) labels
fragmented DNA allowing colorimetric detection of apoptotic cells. Cells were scraped
and plated 24 hours prior to exposure at 2 x105 cell in a volume of 200 µl per well in a 96
well plate. Cell culture media was changed at exposure time. Silica was added to a final
concentration of 66.7 µg/cm2. Cells were exposed to silica for 24 hours before performing
any assessment. After fixing the cells, TiterTACS was used to detect DNA fragmentation
according to manufacturer’s assay protocol. Absorbance at 450 nm was measured.
Caspase-3 Activity Assay for High Throughput Screening (HTS): Caspase-3 Activity was
detected with the Assay for HTS purchased from Calbiochem (EMD). Cells were scraped
and plated 24 hours prior to exposure at 2 x105 cell in a volume of 100 µl per well in a 96
well plate. Cell culture media was changed at exposure time. Silica was added to a final
concentration of 50 µg/cm2 and cells were exposed to silica for 24 hours before
performing any assessment. Caspase-3 activity was detected according to manufacturer’s
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assay protocol. Fluorescence was detected at an excitation wavelength of 400 nm and
emission wavelength of 505 nm using a plate reader.

Data was analyzed and presented as previously described in Aim 1.b.

Results
CHO cells transfected with SR-AIIn were exposed to 50 µg/cm2 of silica for 24
hours. DNA fragmentation and Caspase-3 activity were evaluated and no statistically
significant differences could be found between the mutated constructs and CHO cells
transfected with SR-AIIn or the transfection control (Figures 3.25, and 3.26).
Hamilton et al reported that MARCO (another SR-A) can interact with silica and
induce apoptosis in MARCO transfected CHO cells (R. F. Hamilton, Jr. et al., 2006).
MARCO has a extracellular cysteine rich domain, which is also present in the SR-AI and
not in SR-AII. Therefore the next aim was designed determine whether if the presence of
the extracellular cysteine rich domain in SR-AI could confer functional differences in
comparison with SR-AII.
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Aim III. Evaluate the role of SRCR domain by comparing SR-AI
and SR-AII containing clones in their response to silica.
In this study, all previous experiments have been performed using SR-AII. As
previously described the structural difference between SR-AI and SR-AII is the presence
of the cysteine region (SRCR) at the end of the extracellular region in SR-AI. Previous
studies comparing SR-AI and SR-AII binding to modified LDL showed no functional
difference between both receptors. Because it is unknown if silica binds both receptors
with the same affinity, the present study look for silica binding differences between SRAI and SR-AII. This aim evaluated whether there were any functional differences
between SR-AI and SR-AII transfected cells by examining AcLDL uptake, silica binding,
and silica-induced apoptosis.

Methods
The murine SR-AI cDNA used was obtained from pXmSRI-28 through a kind gift
from Dr. Monty Krieger (Biology Department, MIT, MA). The procedure performed to
subclone the SR-AI cDNA into the vector pcDNA3.1(+) Hygro (Invitrogen) was the
same described in Aim 1.a. for SR-AII. After verifying the DNA sequence of the
constructs, CHO cells were transfected. Measurement of the uptake of AcLDL and silica
binding were performed as previously described in Aim I.b., and apoptosis as previously
described in Aim I.c. Data was analyzed and presented as previously described in Aim
1.b.
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Results
After transfecting CHO cells and selecting them by antibiotic resistance, genomic
incorporation of constructs was verified as previously described (Figure 3.27). The next
step was to determine if both receptors were functional using AcLDL uptake as
previously done. Both receptors were able to internalize AcLDL in amounts that were
statistically significant. In all experiments CHO cells transfected with SR-AII
internalized more AcLDL than SR-AI, but without a statistically significant difference
(Figure 3.28). These results confirmed the functionality of SR-AI and SR-AII in CHO
transfected cells. In order to verify the direct role of SR-A protein expression in the
increase of AcLDL uptake, the specific SR-AI/II blocking antibody 2F8 and the
unspecific PolyI inhibitor, were added 30 minutes before AcLDL exposure. Both
inhibitors in all six experiments performed decreased AcLDL uptake in CHO cells
transfected with SR-AI or SR-AII (Figure 3.29). When data was analyzed (paired T test),
2F8 blocking antibody did not decrease statistically significantly the AcLDL uptake in
SR-AI transfected cells. However, because it was expected to induce only a decrease in
uptake, statistical analysis using one-tail test was performed (instead of 2-tail test).
Results showed a p<0.05 in the decrease of AcLDL in SR-AI transfectants when 2F8 was
used. However, neither silica binding (detected by flow cytometric right angle scatter)
nor apoptosis (detected by TUNEL assay) was different among control EVh, SR-AIh or
SR-AIIh transfected cells (Figure 3.30 and 3.31). In order to verify if silica was able to
induce toxicity in CHO transfected cells, cell cytotoxicity assays were performed. None
of the SR-A transfected cells showed differences in LDH release (Figure 3.32) or
viability (Figure 3.33) at increasing silica doses of 25, 50, and 100 µg/cm2 in comparison
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with EVh control. There was no functional difference between SR-AI and SR-AII when
AcLDL was used. When silica studies were performed comparing SR-AI and SR-AII
transfectants, no difference could be established.
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Summary
Two different mammalian expression vectors pcDNA3.1(+) Hygro and
pcDNA3.1/myc-His-were used in order to induce murine SR-AII expression in CHO
cells. After transfection and antibiotic selection, it was verified that the constructs were
incorporated into the genome. Cells transfected with SR-AII internalized AcLDL in
statistically significant amounts. In addition, the AcLDL internalization was blocked the
SR-A I/II inhibitors: 2F8 antibody and PolyI, confirming SR-AI/II involvement in
AcLDL uptake. Silica binding of transfected CHO cells was not significantly different
from transfected controls. Silica-induced apoptosis was approached by different methods
such as TUNEL, and Caspase 3 activity. None of these methods found a statistically
significant increase in apoptosis after silica exposure compared to their respective
transfected controls. In addition Viability and LDH release were not statistically
significant different between SR-AII and their respective transfected controls. Mutated
cytoplasmic Ser or Thr constructs (S25, S32, S53, and T34) or mutated extracellular
lysine cluster (K-E) constructs were generated in the mammalian expression vector
pcDNA3.1/myc-His-A. All except K-E mutation internalized AcLDL as expected. None
of the constructs produce any change in silica binding or apoptosis. SR-AI construct was
generated and CHO cells were transfected with it. No statistically significant difference
was found between SR-AI and SR-AII in AcLDL uptake, silica binding, silica-induced
apoptosis, viability, and LDH release.
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Discussion
Scavenger receptors are members of a family of membrane receptors, initially
described as a binding site on macrophages that mediate uptake and degradation of
AcLDL (Goldstein, Ho et al., 1979). Today, it is well recognized that scavenger receptors
are a growing family of glycoproteins, implicated as pattern recognition receptors, that
not only have a broad ligand binding ability to polyanions, but also are expressed in
different cell types (Peiser & Gordon, 2001). The scavenger receptors class A (SRA) are
expressed in macrophages and have the ability to bind ligands such as mLDL, negatively
charged particles, silica (Chao, Hamilton et al., 2001; R. F. Hamilton, de Villiers et al.,
2000; Iyer, Hamilton et al., 1996), asbestos (Resnick, Freedman et al., 1993), and LPS
(Hampton et al., 1991). SRAs also have an important role mediating cell adhesion (I.
Fraser, Hughes et al., 1993). There are six members of the SRA family: I, II, III,
MARCO (Macrophage Receptor with Collagenous structure) (Arredouani & Kobzik,
2004), SRCL (SR with C-type lectin) (K. Nakamura et al., 2001), and SCARA5 (Jiang et
al., 2006). SRA-I, SRA-II, and SRA-III are three alternative splice variants of the same
gene. SRA-III is not functional and stays in the endoplasmic reticulum (J. E. Murphy et
al., 2005).
The present study confirmed some previous findings reported about SR-A I/II
binding AcLDL (modified LDL). Two different mammalian expression pcDNA3.1
vectors were designed, and transfected in CHO cells. Both transfectants were tested for
AcLDL uptake. Fluorescent microscopy and fluorescence quantification confirmed that
CHO cells expressing SR-AI or SR-AII bind and uptake AcLDL. Moreover, the use of
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the specific SR-AI/II inhibitor 2F8 and non-specific SR inhibitor PolyI confirmed that the
AcLDL uptake seen was SR-AI/II dependent.
The role of the SR-AI/II cytoplasmic domain in surface expression and modified
LDL internalization has been previously studied (Kosswig, Rice et al., 2003; Morimoto,
Wada et al., 1999). The mouse amino acid sequence of cytoplasmic SRA-II contains
twelve amino acids that could be phosphorylated, and four of these are common in the
SR-A sequence of five species as previously shown in Figure 1.13. These amino acids
correspond to Ser25, Ser32, Ser53, and Thr34 in the SR-A I/II mouse sequence. Fong et
al. reported, working with murine SR-AI/II, that only Serines were phosphorylated and
that phosphorylation happened 2.5 and 5 minutes after AcLDL exposure of mouse
peritoneal macrophages (Fong & Le, 1999). In addition, this same study reported that
CHO cells expressing mutated murine SR-AI Ser25Ala had higher number of AcLDL
binding sites in comparison with non-mutated SR-AI suggestive of an increase in
receptor expression, but unfortunately no statistics were reported.
This present study generated five mutated constructs expressing S25A, S32A,
S53A, T34A (all four Ser/Thr are common in five mammalian species), or K339-342E.
The K339-342E mutation affects the extracellular lysine cluster, which is necessary for
AcLDL binding (Andersson & Freeman, 1998; Doi, Higashino et al., 1993). Each
mutated SR-AII transfectant was exposed to AcLDL. All transfectants incorporated
AcLDL similarly with no statistically significant difference between mutated and normal
SR-AII except the K-E mutant, which failed to uptake AcLDL uptake when compared
with normal SR-AII. The K-E mutant lacks the lysine cluster required for AcLDL, so it
was expected that this mutated SR-AII would not bind AcLDL. In addition, this study
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found that mutated SR-AII behaved as previously reported for mutated SR-AI (Fong &
Le, 1999), except for the Ser25Ala mutation. In the present study the Ser25Ala mutation
showed no difference in AcLDL uptake. The differences between both studies are that
this study used fluorescent-labeled AcLDL, quantification was performed by LSC,
incubation was at 37ºC, and the mutated construct was a SR-AII version, and Fong et al.
study used radiolabeled AcLDL, detection was performed by measuring cell-associated
radioactivity, incubation was at 4ºC, and the mutated construct was a SR-AI version.
Each difference could be a contributor for the difference seen. First, since there are no
studies comparing LSC vs. radioactivity for the quantification of AcLDL, it is not
possible to speculate about the accuracy of each method because the way data is
collected, analyzed and presented is very different. Second, it has been previously
described that when cells are incubated at 4ºC the binding properties of SR-AII are
different than incubated at 37ºC (Andersson & Freeman, 1998; Doi, Higashino et al.,
1993). And third, it has been previously reported that SR-AI and SR-AII have the same
binding affinity for modified LDL (Ashkenas, Penman et al., 1993). Incubation
temperature difference could be a major factor contributing to the different outcome
between both studies, but another important factor to consider is the lack of statistics in
Fong et al. results establishing that the increase in expression was statistically significant
(or not). After verifying SR-AI or SRAII functionality by AcLDL uptake, silica binding
studies determined by cell granularity were evaluated using flow cytometric right angle
scatter (RAS), which correlates with particle binding/uptake (Palecanda & Kobzik,
2000). Unfortunately it was not possible to detect silica binding in any of the SR-AII
constructs.
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The next step was to evaluate silica-induced apoptosis in SR-AII transfectants.
Apoptosis, also known as “programmed cell death”, has been initially described based on
morphological criteria such as nuclear and cytoplasmic condensation, nuclear
fragmentation, and formation of apoptotic bodies with intact plasma membrane (Kerr et
al., 1972). Today some biochemical processes such as caspases induction have been
described associated with the apoptotic process (Thornberry & Lazebnik, 1998).
Different kinds of assay have been developed in order to detect and quantify apoptosis
(Lecoeur, 2002; Plaetzer, Kiesslich et al., 2005). Unfortunately there is no consensus
about which assay or marker is paramount for apoptosis detection. Apoptosis without
caspase activation has been reported (Lovborg, Gullbo et al., 2005), and also DNA
damage (TUNEL assay) with caspase precursor induction, but with no caspase activity or
apoptosis (X. Liu et al., 2005).
TUNEL assay and caspase 3 activity have been previously tested in CHO cells
(Yun et al., 2001) (Abdalah et al., 2006; Tannock & Lee, 2001). In the present study three
assay were used: TiterTACS for DNA fragmentation in adherent cells, TUNEL assay,
and caspase 3 activity. Unfortunately, none of these assays were able to detect a
statistically significant increase in apoptosis in the SR-A I/II transfected group after silica
exposure. Simultaneously TUNEL and Caspase 3 activity assays were evaluated in the
SR-AII mutated transfectants after silica exposure, but no difference was found between
each mutated SR-AII and normal SR-AII.
LDH release correlates with cell lysis as final outcome of cell death and also
correlates with neuronal apoptosis (Lobner, 2000). Since, in the present study, it was not
possible to detect a significant increase in silica-induce apoptosis in any of the SR-AI/II
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transfectants, cell cytotoxicity assays were performed in order to detect any cell toxicity
induced by silica exposure to the transfectants. In the present study no statistically
significant difference in LDH release was found in the SR-A I/II transfected group after
silica exposure. Because LDH release was observed in every silica-exposed group
(including transfection control) SR-A inhibitors were used in order to verify if SR-AI/II
or another SR were involved in silica induced LDH release. Unfortunately, no change
was observed when SR-A inhibitors were used. When viability was detected after
exposing the transfectants to silica, no changes between groups were also observed. A
decrease in cell viability was observed in every group exposed to silica, but with no
statistical difference when SR-AI/II transfectants were compared with their transfected
control group.
The present study was not able to reproduce some of the findings previously
reported by Hamilton et al. such as the silica-induced apoptosis of SR-AII transfected
CHO cells (R. F. Hamilton, de Villiers et al., 2000) or the increase in AcLDL uptake in
the mutated S25A-SR-AII transfected CHO cells (Fong & Le, 1999). The differences
between this study and the one using a S25A-SR-AI mutant had been previously
discussed. The most important differences between this study and the Hamilton et al
study are discussed. The present study used CHO cells, an empty vector for transfection
control, TUNEL assay and caspase activity for apoptosis detection, and LDH and MTS
Viability assays. Hamilton et al. study used CHO ldl-A7 cells, an untransfected groups as
control, histone-bound DNA fragments detection and Sub G0 population for apoptosis
detection, and Trypan blue exclusion for viability. Because each difference could be a
contributor for the different outcomes, they will be discussed separately: First, the most
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important difference between CHO cells and mutant ldl-A7 cells is that ldl-A7 cells are
more susceptible because they cannot uptake LDL directly from the culture media so they
need to synthesize their own LDL in order to survive. It is possible that the interaction of
silica with SR-AII transfected cells interferes with the intrinsic LDL synthetic pathway,
inducing apoptosis only in the ldl-A7 cells since it cannot uptake LDL from the cell
culture media. Second, in both studies antibiotic selection of transfected clones with
hygromycin or G418 was used. Because the insertion of a construct in the transfected cell
followed by the addition of toxic antibiotic in the cell culture media could modify the
normal cell behavior, it is recommended to use an empty vector control, in order to
correct for changes in cell behavior as was done in the present study. Third, as previously
discussed the use of one technique is not sufficient/recommended to establish apoptosis.
The present study used two different assays to detect DNA fragmentation, and one for
caspase 3 activity. Hamilton et al. used two different assays in order to detect DNA
fragments and/or fragmentation. Because none of these assays were common to both
studies, and the final outcome was similar in each study despite using different
techniques, it is not possible to make a conclusion regarding which methods worked
better. Fourth, viability and toxicity assay were also different between both studies.
Hamilton et al. performed only one assay (viability), whose results correlated with the
apoptosis studies. The present study performed cytotoxicity and a different viability
assay, whose results also correlated with the apoptotic assessments of this study,
unfortunately with opposite outcome. The results of the present study only allow to
conclude that further studies are required in order to determine the role of silica in SRAI/II mediated apoptosis and cytotoxicity in this model.
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Figure 3.1
pcDNA 3.1 (+) Hygro and pcDNA 3.1/myc-HisA Mammal Expression Vector©
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Figure 3.2
Sca I Restriction Map of SR-AIIh Construct
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SR-AIIh constructs generated using pcDNA3.1 vectors were digested with the restriction
enzyme ScaI for 3 hours at 37ºC. Then digested DNA was run in an 0.8% agarose gel.
Bands in the digested construct show the presence of the construct containing SR-AII.
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Figure 3.3
Sca I Restriction Map of SR-AIIn Construct
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SR-AIIn constructs generated using pcDNA3.1 vectors were digested with the restriction
enzyme ScaI for 3 hours at 37ºC. Then digested DNA was run in a 0.8% agarose gel.
Bands in the digested construct show the presence of the construct containing SR-AII.
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Figure 3.4
PCR Product Confirmatory of SR-AIIh Incorporation into Genomic CHO
cells

Genomic PCR
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Genomic DNA was isolated from 1-2 million transfected CHO cells. DNA was amplified
by PCR using a T7 primer corresponding to vector sequence, and a SR-AII primer. Then
PCR product was run in a 0.8% agarose gel. Arrowhead shows PCR product band.
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Figure 3.5
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IP and WB of SRAIIn expressed in Transfected CHO Cells
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Ten million cells were lysed and IP with 2F8 antibody and protein G agarose. IP cell
lysate was electhrophoresed and transferred to a nitrocellulose membrane for WB with
monoclonal antibody anti-6X His tag. Bands were detected by enhanced
chemiluminescence (ECL).
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Figure 3.6
Uptake of AcLDL by SR-AIIh Transfected CHO Cells

Uptake of AcLDL by transfected CHO cells with empty vector (EVh) and SRA-IIh. Cells
were exposed to fluorescence labeled AcLDL for 90 minutes. Pictures were taken at 400x
magnification using a FITC/GFP filter (blue light) for Alexa Fluor 488 (first column) and
Rhodamine/Texas Red filter (green light) for propidium iodide (second column). The
overlay at the third column shows co-localization between AcLDL and cells. 400x
magnification with a Zeiss Axioskop Fluorescence Microscope
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Figure 3.7
Uptake of AcLDL by SR-AIIn Transfected CHO Cells

Uptake of AcLDL by transfected CHO cells with empty vector (EVn) and SRA-IIn. Cells
were exposed to fluorescence labeled AcLDL for 90 minutes. Pictures were taken at 400x
magnification using a FITC/GFP filter (blue light) for Alexa Fluor 488 (first column) and
Rhodamine/Texas Red filter (green light) for propidium iodide (second column). The
overlay at the third column shows co-localization between AcLDL and cells. 400x
magnification with a Zeiss Axioskop Fluorescence Microscope
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Figure 3.8
Uptake of AcLDL by SR-AIIh Transfected CHO Cells
(N=6)
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Uptake of AcLDL by CHO cells transfected with SRA-IIh Cells were exposed to
fluorescence labeled AcLDL for 90 minutes. Quantification was performed using a Laser
Scan Cytometer. Differences with its respective unexposed control were analyzed.
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Figure 3.9
Uptake of AcLDL by SR-AIIn Transfected CHO Cells
(N=5)
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Uptake of AcLDL by CHO cells transfected with SRA-IIn Cells were exposed to
fluorescence labeled AcLDL for 90 minutes. Quantification was performed using a Laser
Scan Cytometer. Differences with its respective unexposed control were analyzed.
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Figure 3.10
Inhibition of AcLDL Uptake in SR-AIIh Transfected Cells
(N=6)
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Uptake of AcLDL by transfected CHO cells with SRA-IIh when exposed to the SR-A
inhibitors (ligands in a competition assay). 2F8 a specific SRA-I/II ligand (blocking
antibody) and poly I a nonspecific ligand were used. Cells were pre-incubated 30 minutes
with SR-A inhibitors before being exposed to fluorescence labeled AcLDL for 90
minutes. Quantification was performed using a Laser Scan Cytometer. Ratios with its
respective unexposed control were analyzed and normalized to 100% for the control nonexposed group.
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Figure 3.11
Inhibition of AcLDL Uptake in SR-AIIn Transfected Cells
(N=2)
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Uptake of AcLDL by transfected CHO cells with SRA-IIn when exposed to the SR-A
inhibitors (ligands in a competition assay). 2F8 a specific SRA-I/II ligand (blocking
antibody) and poly I a nonspecific ligand were used. Cells were pre-incubated 30 minutes
with SR-A inhibitors before being exposed to fluorescence labeled AcLDL for 90
minutes. Quantification was performed using a Laser Scan Cytometer. Ratios with its
respective unexposed control were analyzed and normalized to 100% for the control nonexposed group.
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Figure 3.12
Change in Side Scatter in SR-AIIh Transfected Cells After Silica Exposure
(N=2)
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One million cells were exposed to silica at a concentration of 150 µg/ml in an end-overend rotator for 90 minutes at 37ºC. Silica binding/uptake was quantified evaluating cell
granularity by flow cytometric right angle scatter (RAS). Differences with its respective
unexposed control were analyzed.
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Figure 3.13
Change in Side Scatter in SR-AIIn Transfected Cells After Silica Exposure
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Figure 3.14
Change in Side Scatter in SR-AIIn Transfected Cells After Silica Exposure
(N=1)
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One million cells were exposed to silica at a concentration of 150 µg/ml in an end-overend rotator for 90 minutes at 37ºC. Silica binding/uptake was quantified evaluating cell
granularity by flow cytometric right angle scatter (RAS). Differences with its respective
unexposed control were analyzed.
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Figure 3.15
DNA Fragmentation Detected by TiterTACS in SR-AIIn Transfected Cells
After Silica Exposure
(N=3-4)
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Cells were scraped and plated 24 hours prior to exposure at 2 x105 cell in a volume of
200 µl per well in a 96 well plate. Then culture media was changed and silica added to a
final concentration of 66.7 µg/cm2. Cells were exposed to silica for 24 hours. TiterTACS
was used to detect in situ DNA fragmentation. Absorbance was measured. at 450 nm.
Ratios with its respective unexposed control were analyzed and normalized. to 1.0 for the
control non-exposed group.
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Figure 3.16
Caspase-3 Activity in SR-AIIn Transfected Cells After Silica Exposure
(N=2)
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Cells were scraped and plated 24 hours prior to exposure at 2 x105 cell in a volume of
100 µl per well in a 96 well plate. Cell culture media was changed at exposure time.
Silica was added to a final concentration of 50 µg/cm2 and cells were exposed to silica for
24 hours before performing any assessment. Caspase-3 activity was detected using the
Caspase-3 Activity Assay for High Throughput Screening. Fluorescence was detected at
an excitation wavelength of 400 nm and emission wavelength of 505 nm. Ratios with its
respective unexposed control were analyzed and normalized to 100% for the transfection
control.
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Figure 3.17
TUNEL Assay in Transfected Cells Exposed to Silica
(N=4)
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Cells were scraped and 1.5 x 106 cells were transfered to 25 cm2 flasks and preincubated
for 48 hours. Silica was added at a final concentration of 50 µg/cm2. After 24 hourexposure cells were trypsinized, washed and transferred to fresh tubes for DNA labeling
using the APO-BrdU TUNEL Assay Kit. Cells were fixed, stained, and analyzed by flow
cytometry. Differences in percentage with its respective unexposed control were analyzed
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Figure 3.18
LDH Release by SR-AIIh Transfected Cells After Silica Exposure
(N=8)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Silica was added to a final dose of 25, 50 and 100 µg/cm2 per well. After 24 hours
of exposure, cytotoxicity was approached detecting LDH release using Cytotoxic
Detection Assay (LDH). Values were normalized considering that cells exposed to media
only have no LDH release and cells exposed to Triton X-100 1% have 100% of LDH
release.
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Figure 3.19
LDH Release by SR-AIIn Transfected Cells After Silica Exposure
(N=4)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Silica was added to a final dose of 25, 50 and 100 µg/cm2 per well. After 24 hours
of exposure, cytotoxicity was approached detecting LDH release using Cytotoxic
Detection Assay (LDH). Values were normalized considering that cells exposed to media
only have no LDH release and cells exposed to Triton X-100 1% have 100% of LDH
release.
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Figure 3.20
Silica Induced Cytotoxicity in SR-AIIh Transfected Cells
(N=3)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Silica was added to a final dose of 25, 50 and 100 µg/cm2 per well. After 24 hours
of exposure, viability was measured using CellTiter96 Aqueous One Solution Reagent.
Values were normalized considering that cells exposed to media only have 100% of
viability.
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Figure 3.21
LDH Release by SR-AIIn Transfected Cells Exposed to 50 µg/cm2 of Silica
and Treated With SR-As Inhibitors
(N=2)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. The SR-A inhibitors 2F8 blocking antibody (specific for SRA-I/II) and poly I
(nonspecific for SR-AI/II) were used 30 minutes before silica exposure. Then silica was
added to a final dose of 50 µg/cm2 per well. After 24 hours of exposure, cytotoxicity was
approached detecting LDH release using Cytotoxic Detection Assay (LDH). Values were
normalized considering that cells exposed to media only have no LDH release and cells
exposed to Triton X-100 1% have 100% of LDH release.
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Figure 3.22
DNA Sequence of Mutated CD204

Ser 25 Ala

Thr 34 Ala

Ser 32 Ala

Ser 53 Ala

Lysine 339, 342 Glu

Chromatograms corresponding to the DNA sequences of the mutations inserted in murine
SR-AII, as described in the Methods section. Arrowheads point to the mutated bases.
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Figure 3.23
IP and WB of Mutated SRAIIn Protein in Transfected CHO Cells

Ten million cells were lysed and IP with 2F8 antibody and protein G agarose. IP cell
lysate was electhrophoresed and transferred to a nitrocellulose membrane for WB with
monoclonal antibody anti-6X His tag. Bands were detected by enhanced
chemiluminescence (ECL).
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Figure 3.24
Uptake of AcLDL by Mutated SR-AIIn Transfected Cells
(N=3-6)
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Uptake of AcLDL by CHO cells transfected with mutated SRA-II constructs. Cells were
exposed to fluorescence labeled AcLDL for 90 minutes. Quantification was performed
using a Laser Scan Cytometer. Differences with its respective unexposed control were
analyzed.
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Figure 3.25
DNA Fragmentation Detected by TiterTACS in Mutated SRA-IIn
Transfected Cells After Silica Exposure
(N=3-5)

DNA Frangmentation ratio

7
6
5
4
3
2
1
0
EVh

SR-AIIn

S25n

S32n

S53n

T34n

Transfected Construct
Cells were scraped and plated 24 hours prior to exposure at 2 x105 cell in a volume of
200 µl per well in a 96 well plate. Then culture media was changed and silica added to a
final concentration of 66.7 µg/cm2. Cells were exposed to silica for 24 hours. TiterTACS
was used to detect in situ DNA fragmentation. Absorbance was measured. at 450 nm.
Ratios with its respective unexposed control were analyzed.
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Figure 3.26
Caspase-3 Activity in Mutated SR-AIIn Transfected Cells After Silica
Exposure
(N=6)
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Cells were scraped and plated 24 hours prior to exposure at 2 x105 cell in a volume of
100 µl per well in a 96 well plate. Cell culture media was changed at exposure time.
Silica was added to a final concentration of 50 µg/cm2 and cells were exposed to silica for
24 hours before performing any assessment. Caspase-3 activity was detected using the
Caspase-3 Activity Assay for High Throughput Screening. Fluorescence was detected at
an excitation wavelength of 400 nm and emission wavelength of 505 nm. Ratios with its
respective unexposed control were analyzed and normalized to 100% for the transfection
control.
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Figure 3.27
PCR Product Confirmatory of SR-AIh and SR-AIIh Incorporation into
Genomic CHO Cells
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Genomic DNA was isolated from 1-2 million transfected cells. DNA was amplified by
PCR using a T7 primer corresponding to vector sequence, and a SR-AII primer. Then
PCR product was run in a 0.8% agarose gel. Arrowhead shows PCR product band.
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Figure 3.28
Uptake of AcLDL by SR-AIh and SR-AIIh Transfected CHO Cells
(N=6)
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Uptake of AcLDL by CHO cells transfected with SRA-Ih and SR-AIIh. Cells were
exposed to fluorescence labeled AcLDL for 90 minutes. Quantification was performed
using a Laser Scan Cytometer. Differences with its respective unexposed control were
analyzed.
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Figure 3.29
Inhibition of AcLDL Uptake in SR-AIh and SR-AIIh Transfected Cells
(N=6)
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Uptake of AcLDL by transfected CHO cells with SR-AIh and SRA-IIh when exposed to
the SR-A inhibitors (ligands in a competition assay). 2F8 a specific SRA-I/II ligand
(blocking antibody) and poly I a nonspecific ligand were used. Cells were pre-incubated
30 minutes with SR-A inhibitors before being exposed to fluorescence labeled AcLDL
for 90 minutes. Quantification was performed using a Laser Scan Cytometer. Ratios with
its respective unexposed control were analyzed and normalized to 100% for the control
non-exposed group.

145

Figure 3.30
Change in Side Scatter in SR-AIh and SR-AIIh in Transfected Cells After
Silica Exposure
(N=2)
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One million cells were exposed to silica at a concentration of 150 µg/ml in an end-overend rotator for 90 minutes at 37ºC. Silica binding/uptake was quantified evaluating cell
granularity by flow cytometric right angle scatter (RAS). Differences with its respective
unexposed control were analyzed.
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Figure 3.31
TUNEL Assay in SR-AIh and SR-AIIh Transfected Cells After Silica
Exposure
(N=4)
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Cells were scraped and 1.5 x 106 cells were transfered to 25 cm2 flasks and preincubated
for 48 hours. Silica was added at a final concentration of 50 µg/cm2. After 24 hourexposure cells were trypsinized, washed and transferred to fresh tubes for DNA labeling
using the APO-BrdU TUNEL Assay Kit. Cells were fixed, stained, and analyzed by flow
cytometry. Differences in percentage with its respective unexposed control were analyzed

147

Figure 3.32
LDH Release by SR-AIh and SR-AIIh Transfected Cells After Silica
Exposure
(N=8)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Silica was added to a final dose of 25, 50 and 100 µg/cm2 per well. After 24 hours
of exposure, cytotoxicity was approached detecting LDH release using Cytotoxic
Detection Assay (LDH). Values were normalized considering that cells exposed to media
only have no LDH release and cells exposed to Triton X-100 1% have 100% of LDH
release.
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Figure 3.33
Silica Induced Cytotoxicity in SR-AIh and SR-AIIh Transfected Cells
(N=3)
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Cells were trypsinized and plated 24 hours prior to exposure at 50,000 cells in a 96-well
plate. Silica was added to a final dose of 25, 50 and 100 µg/cm2 per well. After 24 hours
of exposure, viability was measured using CellTiter96 Aqueous One Solution Reagent.
Values were normalized considering that cells exposed to media only have 100% of
viability.
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Chapter 4
Final Discussion
The cause of most ILDs is still unknown. In this study two
environmental/occupational agents implicated in causing ILD were studied: crocidolite
asbestos and silica. Both agents can activate inflammation and produce direct injury to
the resident pulmonary cells (Rimal et al., 2005; Rom, Travis et al., 1991). In the asbestos
study, crocidolite alone could not induce either inflammation (prostacyclin production) or
cytotoxicity. In the first case, it required the presence of an RGD protein coating the
fibers, and for the second case one factor or more factors present in the fetal bovine
serum was required. Garcia et al described that human umbilical vein endothelial cells
released prostacyclin after amosite asbestos exposure (Garcia, Gray et al., 1988),
Donaldson et al postulated the involvement of an RGD protein in the cell detachment
induced by the exposure of amosite to A549 cells (human alveolar type II cell line)
(Donaldson, Miller et al., 1993), and Boylan et al describe the role of vitronectin in
crocidolite internalization by mesothelial cells (Boylan, Sanan et al., 1995). No previous
study has described the role of RGD proteins in crocidolite-induced prostacyclin release
by murine alveolar type II cells. In addition there is no previous report describing two
separate responses, such as inflammation and cytotoxicity, in the same group of cells
after crocidolite exposure. These findings show the complexity of the different ways cells
could respond to crocidolite exposure.
In the silica study, our system expressing SR-AI or SR-AII was not sufficient to
induce apoptosis or cytotoxicity with silica exposure and probably other factors or co-
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receptors are necessary. These two studies have in common that the agent by itself
(asbestos or silica) is not sufficient to induce activation/damage of cells. Multiple
interactions with other factors such as ECM proteins (e.g. vitronectin), different receptors
expressed on the surface of cells (e.g. integrins), activation status of the cell environment,
etc. All these variables together (at the right time and in the right place) may be required
to initiate and maintain the response required to produce ILD.
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Future Directions
Role of Asbestos in Lung Epithelial Cells
-

Determine the role of prostacyclin in the ILD animal model: Because prostacyclin
protects and attenuates lung fibrosis in the bleomycin-induced pulmonary fibrosis
model, it will be interesting to determine if decrease in prostacyclin levels correlate
with the development of ILD in different animal models, and also if prostacyclin
therapy could prevent or attenuate the progression of the disease.

-

Determine the role of each VNR and VNR inhibitors in the ILD animal model: VNR
interaction induced prostacyclin biosynthesis, but also VNR bind LAP inducing
activation of TGFβ a key factor in the fibrotic process. So, it is important to
characterize which VNRs are binding coated asbestos and which ones bind LAP
activating TGFβ in the ILD animal model. This will provide more alternatives for
intervention by blocking the VNRs promoting lung fibrosis.

-

Determine the role of Cox 2 inhibitors in the progression of ILD. The use of Cox
inhibitors is very popular currently. In this study, prostacyclin production was Cox 2
mediated. So it is important to determine if blocking prostacyclin production using
Cox 2 inhibitors will accelerate the development of ILD in the animal model.

-

Determine the role of “RGD” proteins in the progression of ILD. Because RGD
proteins (e.g. vitronectin) were involved in the prostacyclin production, it would be
interesting to characterize what RGD proteins in the BAL are coating the fibers in
order to allow cell interaction. This will provide alternative ways for future
intervention.
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Role of Scavenger Receptors in Silica Binding and Apoptosis
-

Identification of proteins that bind the cytoplasmic domain of SR-A I/II after silica
binding. More studies characterizing the proteins associated to SR-AI/II activation
after silica binding are required in order to understand how the apoptotic signal is
initiated.

-

Determine the role of SR-A I/II inhibitors in the ILD animal model. It is necessary to
determine the effect of SR-AI/II inhibitors in the ILD animal model in order to
develop alternatives to future intervention

-

Determine the role of human SR-A I/II in binding and apoptosis when expressed in a
human cell line. More studies characterizing the human SR-AI/II in silica binding and
silica-induced apoptosis are necessary to understand its role in ILD.

153

References
Abdalah, R., Wei, L., Francis, K., & Yu, S. P. (2006). Valinomycin-induced apoptosis in
Chinese hamster ovary cells. Neurosci Lett, 405(1-2), 68-73.
Andersson, L., & Freeman, M. W. (1998). Functional changes in scavenger receptor
binding conformation are induced by charge mutants spanning the entire collagen
domain. J Biol Chem, 273(31), 19592-19601.
Aronoff, D. M., Peres, C. M., Serezani, C. H., Ballinger, M. N., Carstens, J. K., Coleman,
N., et al. (2007). Synthetic prostacyclin analogs differentially regulate
macrophage function via distinct analog-receptor binding specificities. J Immunol,
178(3), 1628-1634.
Arredouani, M. S., & Kobzik, L. (2004). The structure and function of marco, a
macrophage class a scavenger receptor. Cell Mol Biol (Noisy-le-grand), 50 Online
Pub, OL657-665.
Ashkenas, J., Penman, M., Vasile, E., Acton, S., Freeman, M., & Krieger, M. (1993).
Structures and high and low affinity ligand binding properties of murine type I
and type II macrophage scavenger receptors. J Lipid Res, 34(6), 983-1000.
Belton, O., Byrne, D., Kearney, D., Leahy, A., & Fitzgerald, D. J. (2000).
Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with
atherosclerosis. Circulation, 102(8), 840-845.
Bissonnette, E., Carre, B., Dubois, C., & Rola-Pleszczynski, M. (1990). Inhibition of
alveolar macrophage cytotoxicity by asbestos: possible role of prostaglandins. J
Leukoc Biol, 47(2), 129-134.
Boylan, A. M., Sanan, D. A., Sheppard, D., & Broaddus, V. C. (1995). Vitronectin
enhances internalization of crocidolite asbestos by rabbit pleural mesothelial cells
via the integrin alpha v beta 5. J Clin Invest, 96(4), 1987-2001.
Burri, P. H., & Weibel, E. R. (1973). Rontgendiagnostik der Lunge (7th ed.). Bern:
Huber.
Caughey, G. E., Cleland, L. G., Penglis, P. S., Gamble, J. R., & James, M. J. (2001).
Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by
human endothelial cells: selective up-regulation of prostacyclin synthesis by
COX-2. J Immunol, 167(5), 2831-2838.
Chao, S. K., Hamilton, R. F., Pfau, J. C., & Holian, A. (2001). Cell surface regulation of
silica-induced apoptosis by the SR-A scavenger receptor in a murine lung
macrophage cell line (MH-S). Toxicol Appl Pharmacol, 174(1), 10-16.
Chen, Y., Sankala, M., Ojala, J. R., Sun, Y., Tuuttila, A., Isenman, D. E., et al. (2006). A
phage display screen and binding studies with acetylated LDL provide evidence
for the importance of the scavenger receptor cysteine-rich (SRCR) domain in the
ligand-binding function of MARCO. J Biol Chem.
Clement, A., Henrion-Caude, A., & Fauroux, B. (2004). The pathogenesis of interstitial
lung diseases in children. Paediatr Respir Rev, 5(2), 94-97.
Converse, P. J. (2006, 05/12/2006). Integrin, Alpha-V; ITGAV. Retrieved 02/07/2007,
2007, from http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=193210
Covey, S. (2006). The Silicate Class. Retrieved 01/06/2007, 2007, from
http://mineral.galleries.com/Minerals/SILICATE/Class.htm
154

Cutler, N. S., Graves-Deal, R., LaFleur, B. J., Gao, Z., Boman, B. M., Whitehead, R. H.,
et al. (2003). Stromal production of prostacyclin confers an antiapoptotic effect to
colonic epithelial cells. Cancer Res, 63(8), 1748-1751.
DiDonato, D., & Brasaemle, D. L. (2003). Fixation methods for the study of lipid
droplets by immunofluorescence microscopy. J Histochem Cytochem, 51(6), 773780.
Doi, T., Higashino, K., Kurihara, Y., Wada, Y., Miyazaki, T., Nakamura, H., et al.
(1993). Charged collagen structure mediates the recognition of negatively charged
macromolecules by macrophage scavenger receptors. J Biol Chem, 268(3), 21262133.
Donaldson, K., Miller, B. G., Sara, E., Slight, J., & Brown, R. C. (1993). Asbestos fibre
length-dependent detachment injury to alveolar epithelial cells in vitro: role of a
fibronectin-binding receptor. Int J Exp Pathol, 74(3), 243-250.
Dufva, M., Svenningsson, A., & Hansson, G. K. (1995). Differential regulation of
macrophage scavenger receptor isoforms: mRNA quantification using the
polymerase chain reaction. J Lipid Res, 36(11), 2282-2290.
Enterline, P. E., & Henderson, V. (1973). Type of asbestos and respiratory cancer in the
asbestos industry. Arch Environ Health, 27(5), 312-317.
Faust, R. A. (1995). Toxicity Summary for Asbestos. Retrieved 04/13/2007, 2007, from
riskassessment.ornl.gov/documents/Asbestos.pdf
Finkelstein, J. N., & Barrett, E. G. (2000). Alterations in Gene expression in Pulmonary
Cells Following Particle Interactions. In P. Gehr & J. Heyder (Eds.), ParticleLung Interactions (pp. 379-399). New York: Marcel Dekker, Inc.
Fong, L. G., & Le, D. (1999). The processing of ligands by the class A scavenger
receptor is dependent on signal information located in the cytoplasmic domain. J
Biol Chem, 274(51), 36808-36816.
Franks, L. M., Carbonell, A. W., Hemmings, V. J., & Riddle, P. N. (1976). Metastasizing
tumors from serum-supplemented and serum-free cell lines from a C57BL mouse
lung tumor. Cancer Res, 36(3), 1049-1055.
Fraser, I., Hughes, D., & Gordon, S. (1993). Divalent cation-independent macrophage
adhesion inhibited by monoclonal antibody to murine scavenger receptor. Nature,
364(6435), 343-346.
Fraser, R. S., Colman, N., & Muller, N. (2005). Synopsis of Diseases of the Chest (3rd
ed.): Elsevier/Saunders.
Garcia, J. G., Dodson, R. F., & Callahan, K. S. (1989). Effect of environmental
particulates on cultured human and bovine endothelium. Cellular injury via an
oxidant-dependent pathway. Lab Invest, 61(1), 53-61.
Garcia, J. G., Gray, L. D., Dodson, R. F., & Callahan, K. S. (1988). Asbestos-induced
endothelial cell activation and injury. Demonstration of fiber phagocytosis and
oxidant-dependent toxicity. Am Rev Respir Dis, 138(4), 958-964.
Geng, Y., Kodama, T., & Hansson, G. K. (1994). Differential expression of scavenger
receptor isoforms during monocyte-macrophage differentiation and foam cell
formation. Arterioscler Thromb, 14(5), 798-806.
Giancotti, F. G. (2000). Complexity and specificity of integrin signalling. Nat Cell Biol,
2(1), E13-14.

155

Giancotti, F. G., & Ruoslahti, E. (1999). Integrin signaling. Science, 285(5430), 10281032.
Goldstein, J. L., Ho, Y. K., Basu, S. K., & Brown, M. S. (1979). Binding site on
macrophages that mediates uptake and degradation of acetylated low density
lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci U S A,
76(1), 333-337.
Gordon, S. (2002). Pattern recognition receptors: doubling up for the innate immune
response. Cell, 111(7), 927-930.
Gough, P. J., Greaves, D. R., & Gordon, S. (1998). A naturally occurring isoform of the
human macrophage scavenger receptor (SR-A) gene generated by alternative
splicing blocks modified LDL uptake. J Lipid Res, 39(3), 531-543.
Gross, T. J., & Hunninghake, G. W. (2001). Idiopathic pulmonary fibrosis. N Engl J Med,
345(7), 517-525.
Hamilton, R. F., de Villiers, W. J., & Holian, A. (2000). Class A type II scavenger
receptor mediates silica-induced apoptosis in Chinese hamster ovary cell line.
Toxicol Appl Pharmacol, 162(2), 100-106.
Hamilton, R. F., Iyer, L. L., & Holian, A. (1996). Asbestos induces apoptosis in human
alveolar macrophages. Am J Physiol, 271(5 Pt 1), L813-819.
Hamilton, R. F., Jr., Thakur, S. A., Mayfair, J. K., & Holian, A. (2006). MARCO
mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice.
J Biol Chem, 281(45), 34218-34226.
Hampton, R. Y., Golenbock, D. T., Penman, M., Krieger, M., & Raetz, C. R. (1991).
Recognition and plasma clearance of endotoxin by scavenger receptors. Nature,
352(6333), 342-344.
Hayman, E. G., Pierschbacher, M. D., Ohgren, Y., & Ruoslahti, E. (1983). Serum
spreading factor (vitronectin) is present at the cell surface and in tissues. Proc
Natl Acad Sci U S A, 80(13), 4003-4007.
Helliwell, R. J., Adams, L. F., & Mitchell, M. D. (2004). Prostaglandin synthases: recent
developments and a novel hypothesis. Prostaglandins Leukot Essent Fatty Acids,
70(2), 101-113.
Iyer, R., Hamilton, R. F., Li, L., & Holian, A. (1996). Silica-induced apoptosis mediated
via scavenger receptor in human alveolar macrophages. Toxicol Appl Pharmacol,
141(1), 84-92.
Jiang, Y., Oliver, P., Davies, K. E., & Platt, N. (2006). Identification and characterization
of murine SCARA5, a novel class a scavenger receptor that is expressed by
populations of epithelial cells. J Biol Chem, 281(17), 11834-11845.
Kalgutkar, A. S., Marnett, A. B., Crews, B. C., Remmel, R. P., & Marnett, L. J. (2000).
Ester and amide derivatives of the nonsteroidal antiinflammatory drug,
indomethacin, as selective cyclooxygenase-2 inhibitors. J Med Chem, 43(15),
2860-2870.
Kamio, K., Liu, X., Sugiura, H., Togo, S., Kobayashi, T., Kawasaki, S., et al. (2007).
Prostacyclin Analogues Inhibit Fibroblast Contraction of Collagen Gels Through
the cAMP-PKA Pathway. Am J Respir Cell Mol Biol.
Kamp, D. W., Dunn, M. M., Sbalchiero, J. S., Knap, A. M., & Weitzman, S. A. (1994).
Contrasting effects of alveolar macrophages and neutrophils on asbestos-induced
pulmonary epithelial cell injury. Am J Physiol, 266(1 Pt 1), L84-91.

156

Kamp, D. W., Graceffa, P., Pryor, W. A., & Weitzman, S. A. (1992). The role of free
radicals in asbestos-induced diseases. Free Radic Biol Med, 12(4), 293-315.
Kamp, D. W., Greenberger, M. J., Sbalchierro, J. S., Preusen, S. E., & Weitzman, S. A.
(1998). Cigarette smoke augments asbestos-induced alveolar epithelial cell injury:
role of free radicals. Free Radic Biol Med, 25(6), 728-739.
Kamp, D. W., & Weitzman, S. A. (1997). Asbestosis: clinical spectrum and pathogenic
mechanisms. Proc Soc Exp Biol Med, 214(1), 12-26.
Kamp, D. W., & Weitzman, S. A. (1999). The molecular basis of asbestos induced lung
injury. Thorax, 54(7), 638-652.
Kampman, K. A., & McDonald, J. A. (1996). Adhesion Molecules in Lung
Morphogenesis. In P. A. Ward & J. C. Fantone (Eds.), Adhesion Molecules and
the Lung (1st ed., Vol. 90, pp. 99-126). New York: Marcel Dekker, Inc.
Kelley, J. (1998). Occupational Lung Diseases Caused by Asbestos, Silica, and Other
Silicates. In G. L. Baum, J. D. Crapo, B. R. Celli & J. B. Karlinsky (Eds.),
Textbook of Pulmonary Diseases (6th ed., pp. 659-682). Philadelphia: LippincottRaven Publishers.
Kerr, J. F., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer,
26(4), 239-257.
Khan, A. N., Jones, C., & Macdonald, S. (2004, 01/28/2004). Asbestos-Related Disease.
Retrieved 11/29/2006, 2006, from http://www.emedicine.com/radio/topic53.htm
Kim, J. G., Keshava, C., Murphy, A. A., Pitas, R. E., & Parthasarathy, S. (1997). Fresh
mouse peritoneal macrophages have low scavenger receptor activity. J Lipid Res,
38(11), 2207-2215.
Kinnula, V. L., Raivio, K. O., Linnainmaa, K., Ekman, A., & Klockars, M. (1995).
Neutrophil and asbestos fiber-induced cytotoxicity in cultured human mesothelial
and bronchial epithelial cells. Free Radic Biol Med, 18(3), 391-399.
Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., & Krieger, M.
(1990). Type I macrophage scavenger receptor contains alpha-helical and
collagen-like coiled coils. Nature, 343(6258), 531-535.
Kosswig, N., Rice, S., Daugherty, A., & Post, S. R. (2003). Class A scavenger receptormediated adhesion and internalization require distinct cytoplasmic domains. J
Biol Chem, 278(36), 34219-34225.
Lecoeur, H. (2002). Nuclear apoptosis detection by flow cytometry: influence of
endogenous endonucleases. Exp Cell Res, 277(1), 1-14.
Liu, W., Ernst, J. D., & Broaddus, V. C. (2000). Phagocytosis of crocidolite asbestos
induces oxidative stress, DNA damage, and apoptosis in mesothelial cells. Am J
Respir Cell Mol Biol, 23(3), 371-378.
Liu, X., Conner, H., Kobayashi, T., Kim, H., Wen, F., Abe, S., et al. (2005). Cigarette
smoke extract induces DNA damage but not apoptosis in human bronchial
epithelial cells. Am J Respir Cell Mol Biol, 33(2), 121-129.
Lobner, D. (2000). Comparison of the LDH and MTT assays for quantifying cell death:
validity for neuronal apoptosis? J Neurosci Methods, 96(2), 147-152.
Lovborg, H., Gullbo, J., & Larsson, R. (2005). Screening for apoptosis--classical and
emerging techniques. Anticancer Drugs, 16(6), 593-599.

157

Lovgren, A. K., Jania, L. A., Hartney, J. M., Parsons, K. K., Audoly, L. P., Fitzgerald, G.
A., et al. (2006). COX-2-derived prostacyclin protects against bleomycin-induced
pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol, 291(2), L144-156.
MacCorkle, R. A., Slattery, S. D., Nash, D. R., & Brinkley, B. R. (2006). Intracellular
protein binding to asbestos induces aneuploidy in human lung fibroblasts. Cell
Motil Cytoskeleton, 63(10), 646-657.
Marieb, E. N., & Hoehn, K. (2007). Human Anatomy & Physiology (7th ed.). San
Francisco: Pearson Benjamin Cummings.
Mason, R. J., Schwarz, M. I., Hunninghake, G. W., & Musson, R. A. (1999). NHLBI
Workshop Summary. Pharmacological therapy for idiopathic pulmonary fibrosis.
Past, present, and future. Am J Respir Crit Care Med, 160(5 Pt 1), 1771-1777.
McClellan, R. O. (1999). Ambient Airbone Particulate Matter. Toxicology and Standards.
In D. E. Gardner, J. D. Crapo & R. O. McClellan (Eds.), Toxicology of The Lung
(3rd ed., pp. 289-341). Ann Arbor: Taylor & Francis.
McClellan, R. O., & Miller, F. J. (1997). An overview of EPA's proposed revision of the
particulate matter standard. CIIT Activities, 17(4), 1-22.
McKusick, V. A. (1989, 07/18/1994). Vitronectin; VTN. Retrieved 02/07/2007, 2007,
from http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=193190
McKusick, V. A. (2001, 02/27/2003). Prostaglandin I2 synthase; PTGIS. Retrieved
1 1 / 2 8 / 2 0 0 6 ,
2 0 0 6 ,
f r o m
http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=601699
Miki, S., Tsukada, S., Nakamura, Y., Aimoto, S., Hojo, H., Sato, B., et al. (1996).
Functional and possible physical association of scavenger receptor with
cytoplasmic tyrosine kinase Lyn in monocytic THP-1-derived macrophages.
FEBS Lett., 399(3), 241-244.
Morimoto, K., Wada, Y., Hinagata, J., Imanishi, T., Kodama, T., & Doi, T. (1999).
VXFD in the cytoplasmic domain of macrophage scavenger receptors mediates
their efficient internalization and cell-surface expression. Biol Pharm Bull,
22(10), 1022-1026.
Mossman, B. T., Bignon, J., Corn, M., Seaton, A., & Gee, J. B. (1990). Asbestos:
scientific developments and implications for public policy. Science, 247(4940),
294-301.
Mossman, B. T., & Churg, A. (1998). Mechanisms in the pathogenesis of asbestosis and
silicosis. Am J Respir Crit Care Med, 157(5 Pt 1), 1666-1680.
Mossman, B. T., & Gee, J. B. (1989). Asbestos-related diseases. N Engl J Med, 320(26),
1721-1730.
Mossman, B. T., Kamp, D. W., & Weitzman, S. A. (1996). Mechanisms of
carcinogenesis and clinical features of asbestos-associated cancers. Cancer Invest,
14(5), 466-480.
Mossman, B. T., Surinrut, P., Brinton, B. T., Marsh, J. P., Heintz, N. H., Lindau-Shepard,
B., et al. (1996). Transfection of a manganese-containing superoxide dismutase
gene into hamster tracheal epithelial cells ameliorates asbestos-mediated
cytotoxicity. Free Radic Biol Med, 21(2), 125-131.
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., Dalton, S. L., Wu, J., et al.
(1999). The integrin alpha v beta 6 binds and activates latent TGF beta 1: a

158

mechanism for regulating pulmonary inflammation and fibrosis. Cell, 96(3), 319328.
Murakami, S., Nagaya, N., Itoh, T., Kataoka, M., Iwase, T., Horio, T., et al. (2006).
Prostacyclin agonist with thromboxane synthase inhibitory activity (ONO-1301)
attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung
Cell Mol Physiol, 290(1), L59-65.
Murphy, J. E., Tedbury, P. R., Homer-Vanniasinkam, S., Walker, J. H., & Ponnambalam,
S. (2005). Biochemistry and cell biology of mammalian scavenger receptors.
Atherosclerosis, 182(1), 1-15.
Murphy, J. F., Steele, C., Belton, O., & Fitzgerald, D. J. (2003). Induction of
cyclooxygenase-1 and -2 modulates angiogenic responses to engagement of
alphavbeta3. Br J Haematol, 121(1), 157-164.
Nakamura, K., Funakoshi, H., Tokunaga, F., & Nakamura, T. (2001). Molecular cloning
of a mouse scavenger receptor with C-type lectin (SRCL)(1), a novel member of
the scavenger receptor family. Biochim Biophys Acta, 1522(1), 53-58.
Nakamura, T., Hinagata, J., Tanaka, T., Imanishi, T., Wada, Y., Kodama, T., et al.
(2002). HSP90, HSP70, and GAPDH directly interact with the cytoplasmic
domain of macrophage scavenger receptors. Biochem.Biophys.Res.Commun.,
290(2), 858-864.
Nemery, B., Bast, A., Behr, J., Borm, P. J., Bourke, S. J., Camus, P. H., et al. (2001).
Interstitial lung disease induced by exogenous agents: factors governing
susceptibility. Eur Respir J Suppl, 32, 30s-42s.
Obot, C. J., Morandi, M. T., Beebe, T. P., Hamilton, R. F., & Holian, A. (2002). Surface
components of airborne particulate matter induce macrophage apoptosis through
scavenger receptors. Toxicol Appl Pharmacol, 184(2), 98-106.
Ottaviani, M. F., Venturi, F., Pokhrel, M. R., Schmutz, T., & Bossmann, S. H. (2001).
Physicochemical Studies on the Adsorption Properties of Asbestos. J Colloid
Interface Sci, 238(2), 371-380.
Palecanda, A., & Kobzik, L. (2000). Alveolar macrophage-environmental particle
interaction: analysis by flow cytometry. Methods, 21(3), 241-247.
Pande, P., Mosleh, T. A., & Aust, A. E. (2006). Role of alphavbeta5 integrin receptor in
endocytosis of crocidolite and its effect on intracellular glutathione levels in
human lung epithelial (A549) cells. Toxicol Appl Pharmacol, 210(1-2), 70-77.
Peiser, L., & Gordon, S. (2001). The function of scavenger receptors expressed by
macrophages and their role in the regulation of inflammation. Microbes Infect,
3(2), 149-159.
Peterson, M. W., & Schwartz, D. A. (1999). Effects of Fiber Aerosols on the Lung and
Chest Wall. In D. L. Swift & W. M. Foster (Eds.), Air Pollutants and the
Respiratory Tract (1st ed., Vol. 128, pp. 219-250). New York: Marcel Dekker,
Inc.
Pittet, J. F., Griffiths, M. J., Geiser, T., Kaminski, N., Dalton, S. L., Huang, X., et al.
(2001). TGF-beta is a critical mediator of acute lung injury. J Clin Invest,
107(12), 1537-1544.
Plaetzer, K., Kiesslich, T., Oberdanner, C. B., & Krammer, B. (2005). Apoptosis
following photodynamic tumor therapy: induction, mechanisms and detection.
Curr Pharm Des, 11(9), 1151-1165.

159

Platt, N., & Gordon, S. (2001). Is the class A macrophage scavenger receptor (SR-A)
multifunctional? - The mouse's tale. J.Clin.Invest, 108(5), 649-654.
Powel, F. L. (1998). Structure and Function of the Respiratory System. In L. R. Johnson
(Ed.), Essential Medical Physiology (2nd ed., pp. 239-254). Philadelphia:
Lippincott-Raven Publishers.
Raabe, O. G. (1999). Respiratory Exposure to Air Pollutants. In D. L. Swift & W. M.
Foster (Eds.), Air Pollutants and the Respiratory Tract (1st ed., Vol. 128, pp. 3973). New York: Marcel Dekker, Inc.
Resnick, D., Freedman, N. J., Xu, S., & Krieger, M. (1993). Secreted extracellular
domains of macrophage scavenger receptors form elongated trimers which
specifically bind crocidolite asbestos. J Biol Chem, 268(5), 3538-3545.
Rimal, B., Greenberg, A. K., & Rom, W. N. (2005). Basic pathogenetic mechanisms in
silicosis: current understanding. Curr Opin Pulm Med, 11(2), 169-173.
Roberts, K., Yokoyama, W. M., Kehn, P. J., & Shevach, E. M. (1991). The vitronectin
receptor serves as an accessory molecule for the activation of a subset of
gamma/delta T cells. J Exp Med, 173(1), 231-240.
Rom, W. N., Travis, W. D., & Brody, A. R. (1991). Cellular and molecular basis of the
asbestos-related diseases. Am Rev Respir Dis, 143(2), 408-422.
Ruoslahti, E. (2003). The RGD story: a personal account. Matrix Biol, 22(6), 459-465.
Samet, J. M. (2000). Occupational Pulmonary Disorders. In L. Goldman & J. C. Bennett
(Eds.), Cecil Textbook of Medicine (21st ed., pp. 419-424). Philadelphia: W.B.
Saunders Company.
Schvartz, I., Seger, D., & Shaltiel, S. (1999). Vitronectin. Int J Biochem Cell Biol, 31(5),
539-544.
Seiffert, D. (1997). Constitutive and regulated expression of vitronectin. Histol
Histopathol, 12(3), 787-797.
Sheppard, D. (2005). Integrin-mediated activation of latent transforming growth factor
beta. Cancer Metastasis Rev, 24(3), 395-402.
Stoner, G. D., Kikkawa, Y., Kniazeff, A. J., Miyai, K., & Wagner, R. M. (1975). Clonal
isolation of epithelial cells from mouse lung adenoma. Cancer Res, 35(8), 21772185.
Takagi, J. (2004). Structural basis for ligand recognition by RGD (Arg-Gly-Asp)dependent integrins. Biochem Soc Trans, 32(Pt3), 403-406.
Tannock, I. F., & Lee, C. (2001). Evidence against apoptosis as a major mechanism for
reproductive cell death following treatment of cell lines with anti-cancer drugs. Br
J Cancer, 84(1), 100-105.
Tatrai, E., Brozik, M., Kovacikova, Z., & Horvath, M. (2005). The effect of asbestos and
stone-wool fibres on some chemokines and redox system of pulmonary alveolar
macrophages and pneumocytes type II. Biomed Pap Med Fac Univ Palacky
Olomouc Czech Repub, 149(2), 357-361.
Thornberry, N. A., & Lazebnik, Y. (1998). Caspases: enemies within. Science,
281(5381), 1312-1316.
Toews, G. B. (2000). Interstitial Lung Disease. In L. Goldman & J. C. Bennett (Eds.),
Cecil Textbook of Medicine (21st ed., pp. 409-419). Philadelphia: W.B. Saunders
Company.

160

Tsuda, A., Stringer, B. K., Mijailovich, S. M., Rogers, R. A., Hamada, K., & Gray, M. L.
(1999). Alveolar cell stretching in the presence of fibrous particles induces
interleukin-8 responses. Am J Respir Cell Mol Biol, 21(4), 455-462.
Wagner, G. R. (1997). Asbestosis and silicosis. Lancet, 349(9061), 1311-1315.
Wang, L., Antonini, J. M., Rojanasakul, Y., Castranova, V., Scabilloni, J. F., & Mercer,
R. R. (2003). Potential role of apoptotic macrophages in pulmonary inflammation
and fibrosis. J Cell Physiol, 194(2), 215-224.
Wang, L., Scabilloni, J. F., Antonini, J. M., Rojanasakul, Y., Castranova, V., & Mercer,
R. R. (2005). Induction of Secondary Apoptosis, Inflammation and Lung Fibrosis
After Intratracheal Instillation of Apoptotic Cells in Rats. Am J Physiol Lung Cell
Mol Physiol.
Weibel, E. R. (1963). Morphometry of The Human Lung (7th ed.). New York: SpringerVerlag.
Whitehead, P. (2001). Silicate Mineralogy. Retrieved 01/06/2007, 2007, from
http://tesla.jcu.edu.au/Schools/Earth/EA1001/Mineralogy/Silicates.html
Wu, J., Liu, W., Koenig, K., Idell, S., & Broaddus, V. C. (2000). Vitronectin adsorption
to chrysotile asbestos increases fiber phagocytosis and toxicity for mesothelial
cells. Am J Physiol Lung Cell Mol Physiol, 279(5), L916-923.
Yamamoto, K., Nishimura, N., Doi, T., Imanishi, T., Kodama, T., Suzuki, K., et al.
(1997). The lysine cluster in the collagen-like domain of the scavenger receptor
provides for its ligand binding and ligand specificity. FEBS Lett, 414(2), 182-186.
Yun, Z., Takagi, M., & Yoshida, T. (2001). Effect of antioxidants on the apoptosis of
CHO cells and production of tissue plasminogen activator in suspension culture. J
Biosci Bioeng, 91(6), 581-585.

161

